[
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2026-01-30",
    "accession_number": "0001193125-26-030518",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312526030518/d72347d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2026-01-30",
    "accession_number": "0000872589-26-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000004/regn-20260130.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2026-01-30",
    "accession_number": "0001110803-26-000014",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000014/ilmn-20260130.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2026-01-30",
    "accession_number": "0001104659-26-008698",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000110465926008698/tm264540d1_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2026-01-29",
    "accession_number": "0001193125-26-029401",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526029401/d170996d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2026-01-26",
    "accession_number": "0001193125-26-021718",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526021718/d100834d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2026-01-21",
    "accession_number": "0000200406-26-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000002/jnj-20260121.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2026-01-14",
    "accession_number": "0000875045-26-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/biib-20260113.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2026-01-13",
    "accession_number": "0001110803-26-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000009/ilmn-20260113.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001140361-26-000929",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036126000929/ef20062582_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001104659-26-002691",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926002691/tm262861d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001682852-26-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000007/mrna-20260112.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001193125-26-010508",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312526010508/d93149d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001628280-26-001755",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000162828026001755/alny-20260111.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001193125-26-010116",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526010116/srpt-20260112.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001140361-26-000893",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036126000893/ef20062670_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001104659-26-002757",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465926002757/srrk-20260112x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001104659-26-002861",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465926002861/tm262952d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2026-01-12",
    "accession_number": "0001628280-26-001808",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000162828026001808/txg-20260111.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2026-01-08",
    "accession_number": "0001110803-26-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000006/ilmn-20260108.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2026-01-07",
    "accession_number": "0001551152-26-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000002/abbv-20260107.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2026-01-07",
    "accession_number": "0001140361-26-000435",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036126000435/ef20062477_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2026-01-05",
    "accession_number": "0001682852-26-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/mrna-20260105.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-12-29",
    "accession_number": "0001193125-25-332352",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000119312525332352/d33273d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-12-22",
    "accession_number": "0001193125-25-327828",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525327828/d45090d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-12-19",
    "accession_number": "0001193125-25-325856",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525325856/d49247d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-12-19",
    "accession_number": "0001193125-25-326969",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/d32354d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-12-17",
    "accession_number": "0001193125-25-322704",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/d848371d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-12-16",
    "accession_number": "0000078003-25-000167",
    "description": "PFIZER 8-K DECEMBER 16, 2025",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000167/pfe-20251216.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-12-12",
    "accession_number": "0000879169-25-000122",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000122/incy-20251210.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-12-11",
    "accession_number": "0001628280-25-056533",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025056533/mdgl-20251205.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-12-11",
    "accession_number": "0001193125-25-315047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312525315047/d201569d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-12-11",
    "accession_number": "0001193125-25-315032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525315032/d55628d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-12-08",
    "accession_number": "0001193125-25-310588",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525310588/d15497d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-12-05",
    "accession_number": "0001104659-25-118664",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925118664/tm2532406d4_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-12-05",
    "accession_number": "0001674101-25-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000031/vrt-20251204.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-12-04",
    "accession_number": "0001628280-25-055388",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000162828025055388/mrk-20251204.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-12-03",
    "accession_number": "0001628280-25-055084",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000162828025055084/alny-20251202.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-12-02",
    "accession_number": "0001104659-25-117522",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925117522/tm2532170d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-11-25",
    "accession_number": "0001193125-25-297576",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312525297576/d22271d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-11-24",
    "accession_number": "0001628280-25-053816",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/mrna-20251119.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-11-24",
    "accession_number": "0000914475-25-000186",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/nbix-20251121.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-11-21",
    "accession_number": "0001193125-25-291406",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312525291406/d80089d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-11-21",
    "accession_number": "0000059478-25-000271",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-11-20",
    "accession_number": "0001628280-25-053318",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000162828025053318/mrna-20251120.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-11-20",
    "accession_number": "0001193125-25-288896",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000119312525288896/d38144d8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-11-19",
    "accession_number": "0001104659-25-113968",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465925113968/tm2531634d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-11-18",
    "accession_number": "0001140361-25-042607",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125042607/ef20059419_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-11-17",
    "accession_number": "0001193125-25-284609",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312525284609/d31230d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-11-14",
    "accession_number": "0001104659-25-111956",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925111956/tm2530774d2_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-11-14",
    "accession_number": "0001104659-25-111931",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925111931/srrk-20251114x8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-11-14",
    "accession_number": "0001628280-25-052154",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000162828025052154/txg-20251112.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-11-14",
    "accession_number": "0001674101-25-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000028/vrt-20251113.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-11-13",
    "accession_number": "0000078003-25-000159",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000159/pfe-20251113.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-11-13",
    "accession_number": "0001628280-25-052055",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000162828025052055/mrna-20251112.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-11-12",
    "accession_number": "0001193125-25-277870",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312525277870/d36759d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-11-10",
    "accession_number": "0001140361-25-041380",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125041380/ny20057651x6_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-11-10",
    "accession_number": "0001140361-25-041225",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125041225/ef20058520_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-11-06",
    "accession_number": "0001682852-25-000073",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000073/mrna-20251106.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-11-06",
    "accession_number": "0001104659-25-107727",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925107727/tm2529763d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-11-06",
    "accession_number": "0001770787-25-000058",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000058/txg-20251106.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-11-04",
    "accession_number": "0000078003-25-000149",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000149/pfe-20251104.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2025-11-04",
    "accession_number": "0000318154-25-000070",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815425000070/amgn-20251104.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-11-04",
    "accession_number": "0001628280-25-048525",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025048525/mdgl-20251104.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-11-03",
    "accession_number": "0001140361-25-040066",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125040066/ef20058056_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-11-03",
    "accession_number": "0000875320-25-000230",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000230/vrtx-20251103.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-11-03",
    "accession_number": "0001124140-25-000090",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000090/exas-20251103.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-11-03",
    "accession_number": "0001193125-25-262591",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525262591/srpt-20251103.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K/A",
    "filing_date": "2025-11-03",
    "accession_number": "0001140361-25-040220",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125040220/ef20058178_8ka.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-11-03",
    "accession_number": "0001193125-25-261623",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312525261623/d10924d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-10-31",
    "accession_number": "0001551152-25-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000047/abbv-20251031.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0001104659-25-103974",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465925103974/tm2529620d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0000014272-25-000147",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/bmy-20251030.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0000059478-25-000251",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000251/lly-20251030.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0000882095-25-000044",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000044/gild-20251030.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0000875045-25-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000047/biib-20251030.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0001110803-25-000071",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000071/ilmn-20251030.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-10-30",
    "accession_number": "0001628280-25-047342",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000162828025047342/alny-20251030.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-10-29",
    "accession_number": "0001140361-25-039650",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125039650/ef20057869_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-10-28",
    "accession_number": "0000872589-25-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000087258925000026/regn-20251028.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-10-28",
    "accession_number": "0000879169-25-000115",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000115/incy-20251028.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-10-28",
    "accession_number": "0000914475-25-000180",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000180/nbix-20251028.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-10-27",
    "accession_number": "0001048477-25-000104",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000104/bmrn-20251027.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-10-22",
    "accession_number": "0001674101-25-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000020/vrt-20251022.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-10-14",
    "accession_number": "0000200406-25-000201",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-10-14",
    "accession_number": "0000875045-25-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000040/biib-20251014.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-10-14",
    "accession_number": "0001104659-25-098894",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925098894/tm2528675d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-10-14",
    "accession_number": "0001628280-25-044836",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025044836/vrt-20251013.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-10-07",
    "accession_number": "0001048477-25-000101",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000101/bmrn-20251007.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-10-06",
    "accession_number": "0000882095-25-000041",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000041/gild-20251006.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-10-06",
    "accession_number": "0001104659-25-096921",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465925096921/tm2528010d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-10-03",
    "accession_number": "0001551152-25-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000043/abbv-20251003.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-10-03",
    "accession_number": "0001104659-25-096632",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465925096632/tm2527974d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-10-03",
    "accession_number": "0001193125-25-230201",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312525230201/d19737d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-09-23",
    "accession_number": "0001104659-25-092317",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925092317/tm2526733d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-09-22",
    "accession_number": "0001140361-25-035634",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125035634/ef20055880_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-09-12",
    "accession_number": "0001193125-25-202366",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312525202366/d949176d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-09-11",
    "accession_number": "0001104659-25-089245",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925089245/tm2525781d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-09-10",
    "accession_number": "0001193125-25-199686",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312525199686/d72540d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-09-09",
    "accession_number": "0000200406-25-000190",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-09-09",
    "accession_number": "0000310158-25-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000031015825000047/mrk-20250909.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-09-03",
    "accession_number": "0001674101-25-000014",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000014/vrt-20250903.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-09-02",
    "accession_number": "0001140361-25-033541",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125033541/ef20054942_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-29",
    "accession_number": "0001193125-25-192794",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525192794/d945054d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-21",
    "accession_number": "0001193125-25-184625",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525184625/d938350d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-08-21",
    "accession_number": "0001140361-25-032176",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125032176/ef20054334_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-08-20",
    "accession_number": "0001193125-25-184093",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-20",
    "accession_number": "0001674101-25-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000011/vrt-20250820.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-08-14",
    "accession_number": "0000882095-25-000035",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000035/gild-20250810.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-13",
    "accession_number": "0001193125-25-179819",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525179819/d59666d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-12",
    "accession_number": "0001193125-25-178982",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312525178982/d25970d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-08-11",
    "accession_number": "0001048477-25-000098",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/bmrn-20250805.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-08-07",
    "accession_number": "0000059478-25-000202",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000202/lly-20250807.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-08-07",
    "accession_number": "0000882095-25-000030",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000030/gild-20250807.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-08-07",
    "accession_number": "0000879169-25-000108",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000108/incy-20250804.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-08-07",
    "accession_number": "0001104659-25-075189",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925075189/tm2522162d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-08-07",
    "accession_number": "0001770787-25-000048",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000048/txg-20250807.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-08-06",
    "accession_number": "0001124140-25-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000081/exas-20250806.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-08-06",
    "accession_number": "0001558370-25-010399",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025010399/srrk-20250806x8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-08-05",
    "accession_number": "0000078003-25-000136",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000136/pfe-20250805.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2025-08-05",
    "accession_number": "0000318154-25-000054",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815425000054/amgn-20250805.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-08-05",
    "accession_number": "0001628280-25-037596",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025037596/mdgl-20250805.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-08-04",
    "accession_number": "0000882095-25-000022",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000022/gild-20250730.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-08-04",
    "accession_number": "0000875320-25-000213",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000213/vrtx-20250804.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-08-04",
    "accession_number": "0001048477-25-000088",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000088/bmrn-20250804.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-08-01",
    "accession_number": "0000872589-25-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000087258925000017/regn-20250801.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-08-01",
    "accession_number": "0001682852-25-000041",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000041/mrna-20250801.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-08-01",
    "accession_number": "0001048477-25-000086",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/bmrn-20250730.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-07-31",
    "accession_number": "0001551152-25-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000036/abbv-20250731.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-07-31",
    "accession_number": "0000014272-25-000129",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/bmy-20250731.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-07-31",
    "accession_number": "0000875045-25-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000035/biib-20250731.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-07-31",
    "accession_number": "0001110803-25-000057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000057/ilmn-20250731.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-07-31",
    "accession_number": "0001178670-25-000089",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000089/alny-20250731.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-07-30",
    "accession_number": "0001104659-25-071928",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000110465925071928/tm2522007d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-07-30",
    "accession_number": "0000914475-25-000157",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000157/nbix-20250730.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-07-30",
    "accession_number": "0001140361-25-027949",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125027949/ef20052929_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-07-30",
    "accession_number": "0001674101-25-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000167410125000006/vrt-20250730.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-07-29",
    "accession_number": "0001104659-25-071380",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/tm2521736d1_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-07-29",
    "accession_number": "0000879169-25-000100",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000100/incy-20250729.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-07-25",
    "accession_number": "0001140361-25-027350",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125027350/ef20052589_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-07-22",
    "accession_number": "0001628280-25-035506",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025035506/mdgl-20250717.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-07-21",
    "accession_number": "0001193125-25-161516",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525161516/d882671d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-07-18",
    "accession_number": "0001193125-25-160804",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000119312525160804/d909980d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-07-17",
    "accession_number": "0001628280-25-035130",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025035130/vrt-20250717.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-07-16",
    "accession_number": "0000200406-25-000170",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-07-16",
    "accession_number": "0000950170-25-096257",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017025096257/srpt-20250714.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-07-07",
    "accession_number": "0000875045-25-000027",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000027/biib-20250707.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-07-03",
    "accession_number": "0001551152-25-000034",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000034/abbv-20250703.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-06-27",
    "accession_number": "0001104659-25-063675",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465925063675/tm2519327d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-06-23",
    "accession_number": "0000875045-25-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000023/biib-20250617.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-06-23",
    "accession_number": "0001193125-25-144290",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312525144290/d66921d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-06-20",
    "accession_number": "0001628280-25-032358",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025032358/mdgl-20250620.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-06-20",
    "accession_number": "0001558370-25-008742",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837025008742/bpmc-20250618x8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-06-20",
    "accession_number": "0000950142-25-001652",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000095014225001652/eh250644853_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-06-18",
    "accession_number": "0001104659-25-060637",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465925060637/tm2518262d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-06-18",
    "accession_number": "0001178670-25-000076",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000076/alny-20250612.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-06-18",
    "accession_number": "0001558370-25-008711",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025008711/srrk-20250618x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-06-18",
    "accession_number": "0001104659-25-060626",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925060626/tm2518235d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-06-16",
    "accession_number": "0001124140-25-000046",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000046/exas-20250612.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-06-12",
    "accession_number": "0001140361-25-022267",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125022267/ef20050532_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-06-11",
    "accession_number": "0000879169-25-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000062/incy-20250610.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-06-10",
    "accession_number": "0000200406-25-000152",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-06-10",
    "accession_number": "0001140361-25-022001",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125022001/ef20050437_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-06-06",
    "accession_number": "0000950170-25-083131",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/srpt-20250605.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-06-05",
    "accession_number": "0001770787-25-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000040/txg-20250603.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-06-04",
    "accession_number": "0001628280-25-029224",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025029224/vrt-20250604.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-06-03",
    "accession_number": "0001558370-25-008364",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025008364/srrk-20250603x8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-06-02",
    "accession_number": "0001104659-25-055143",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465925055143/tm2516831d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-05-30",
    "accession_number": "0000914475-25-000139",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000139/nbix-20250530.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-05-29",
    "accession_number": "0001104659-25-054131",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465925054131/tm2516491d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-05-28",
    "accession_number": "0001628280-25-028038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025028038/vrt-20250521.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2025-05-27",
    "accession_number": "0000950170-25-077233",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000095017025077233/amgn-20250523.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-05-23",
    "accession_number": "0001110803-25-000051",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000051/ilmn-20250521.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-05-23",
    "accession_number": "0001558370-25-008134",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025008134/srrk-20250522x8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-05-22",
    "accession_number": "0001193125-25-125040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/d947689d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-05-22",
    "accession_number": "0000914475-25-000120",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000120/nbix-20250521.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-05-19",
    "accession_number": "0001193125-25-122480",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312525122480/d60311d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-05-19",
    "accession_number": "0000875320-25-000199",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000199/vrtx-20250519.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-05-19",
    "accession_number": "0001140361-25-019620",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125019620/ef20049265_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-05-16",
    "accession_number": "0001193125-25-121296",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525121296/d833625d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-05-14",
    "accession_number": "0000875320-25-000194",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/vrtx-20250514.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-05-14",
    "accession_number": "0000879169-25-000059",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000059/incy-20250511.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-05-14",
    "accession_number": "0001558370-25-007650",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025007650/srrk-20250514x8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-05-14",
    "accession_number": "0001770787-25-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000035/txg-20250512.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-05-13",
    "accession_number": "0001104659-25-047402",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/tm2513856d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-05-13",
    "accession_number": "0001178670-25-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000062/alny-20250508.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-05-12",
    "accession_number": "0001193125-25-117854",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312525117854/d13940d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-05-12",
    "accession_number": "0001104659-25-047324",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925047324/tm2514746d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-05-08",
    "accession_number": "0000059478-25-000138",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000138/lly-20250505.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-05-08",
    "accession_number": "0000882095-25-000015",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000015/gild-20250507.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-05-08",
    "accession_number": "0001110803-25-000044",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000044/ilmn-20250508.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-05-08",
    "accession_number": "0001104659-25-046121",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925046121/tm2513945d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-05-08",
    "accession_number": "0001770787-25-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000031/txg-20250506.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-05-07",
    "accession_number": "0001140361-25-017742",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125017742/ef20048602_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-05-05",
    "accession_number": "0000875320-25-000171",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000171/vrtx-20250505.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-05-05",
    "accession_number": "0001682852-25-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000036/mrna-20250430.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-05-05",
    "accession_number": "0000914475-25-000099",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000099/nbix-20250505.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0000059478-25-000129",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/lly-20250501.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0000318154-25-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815425000018/amgn-20250501.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001682852-25-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/mrna-20250501.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0000875045-25-000014",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000014/biib-20250501.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001628280-25-021314",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025021314/mdgl-20250501.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001048477-25-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000049/bmrn-20250501.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001124140-25-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000042/exas-20250501.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001178670-25-000050",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000050/alny-20250501.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-05-01",
    "accession_number": "0001558370-25-006050",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837025006050/bpmc-20250501x8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-04-30",
    "accession_number": "0000200406-25-000141",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-04-30",
    "accession_number": "0001140361-25-016562",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125016562/ef20048172_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-04-29",
    "accession_number": "0000078003-25-000111",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000111/pfe-20250429.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-04-29",
    "accession_number": "0001804220-25-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422025000020/regn-20250429.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-04-29",
    "accession_number": "0000879169-25-000053",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000053/incy-20250429.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-04-29",
    "accession_number": "0001124140-25-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000032/exas-20250429.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-04-28",
    "accession_number": "0000078003-25-000109",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000109/pfe-20250424.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-04-28",
    "accession_number": "0001104659-25-039854",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925039854/tm2513330d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-04-25",
    "accession_number": "0001551152-25-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000026/abbv-20250425.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-04-24",
    "accession_number": "0001104659-25-038301",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465925038301/tm2512885d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-04-24",
    "accession_number": "0000014272-25-000089",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427225000089/bmy-20250424.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-04-24",
    "accession_number": "0000882095-25-000009",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000009/gild-20250424.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-04-23",
    "accession_number": "0001628280-25-018915",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025018915/vrt-20250423.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-04-17",
    "accession_number": "0001628280-25-018242",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000162828025018242/mdgl-20250416.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-04-15",
    "accession_number": "0000200406-25-000110",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/jnj-20250415.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-04-04",
    "accession_number": "0000914475-25-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000081/nbix-20250402.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-04-03",
    "accession_number": "0000200406-25-000106",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000106/jnj-20250331.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-04-03",
    "accession_number": "0001551152-25-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000023/abbv-20250403.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-03-28",
    "accession_number": "0000875320-25-000156",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000156/vrtx-20250328.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-03-25",
    "accession_number": "0001110803-25-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000032/ilmn-20250325.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-03-24",
    "accession_number": "0001110803-25-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000029/ilmn-20250318.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-03-21",
    "accession_number": "0001178670-25-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000038/alny-20250320.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-03-21",
    "accession_number": "0001558370-25-003477",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025003477/srrk-20250321x8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-03-12",
    "accession_number": "0001104659-25-023012",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465925023012/tm258955d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-03-12",
    "accession_number": "0001140361-25-008178",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125008178/ef20045255_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-03-12",
    "accession_number": "0001104659-25-022968",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925022968/tm258931d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-03-11",
    "accession_number": "0001193125-25-051461",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312525051461/d916063d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-03-10",
    "accession_number": "0001110803-25-000025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000025/ilmn-20250310.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-03-07",
    "accession_number": "0001628280-25-011205",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025011205/vrt-20250307.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-03-05",
    "accession_number": "0001178670-25-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000031/alny-20250303.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-03-03",
    "accession_number": "0001193125-25-044103",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/d38831d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-02-27",
    "accession_number": "0001558370-25-001681",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025001681/srrk-20250227x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-02-27",
    "accession_number": "0001104659-25-018223",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925018223/tm257259d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-02-26",
    "accession_number": "0001193125-25-036773",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-02-26",
    "accession_number": "0001104659-25-017490",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/tm255723d7_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-02-26",
    "accession_number": "0001193125-25-035787",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312525035787/d924231d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-02-26",
    "accession_number": "0000950170-25-027717",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017025027717/srpt-20250226.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-02-24",
    "accession_number": "0001193125-25-033463",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312525033463/d876806d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-02-20",
    "accession_number": "0001193125-25-030851",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-02-19",
    "accession_number": "0001104659-25-015015",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/tm255723d4_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2025-02-19",
    "accession_number": "0001048477-25-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847725000004/bmrn-20250219.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-02-19",
    "accession_number": "0001124140-25-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000018/exas-20250219.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-02-19",
    "accession_number": "0001140361-25-005080",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036125005080/ef20043828_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-02-18",
    "accession_number": "0001140361-25-005012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125005012/ef20043809_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-02-14",
    "accession_number": "0001104659-25-013467",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/tm256372d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-02-14",
    "accession_number": "0001682852-25-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000006/mrna-20250214.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-02-14",
    "accession_number": "0001193125-25-026683",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/d875089d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-02-13",
    "accession_number": "0001178670-25-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000020/alny-20250213.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-02-13",
    "accession_number": "0001558370-25-000903",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837025000903/bpmc-20250213x8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-02-12",
    "accession_number": "0001193125-25-025057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525025057/d868986d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-02-12",
    "accession_number": "0000875045-25-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504525000004/biib-20250212.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-02-12",
    "accession_number": "0001770787-25-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000011/txg-20250212.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-02-12",
    "accession_number": "0001628280-25-005006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828025005006/vrt-20250212.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2025-02-11",
    "accession_number": "0000882095-25-000003",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209525000003/gild-20250211.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2025-02-10",
    "accession_number": "0000875320-25-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532025000029/vrtx-20250204.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-02-10",
    "accession_number": "0001628280-25-004514",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000162828025004514/incy-20250210.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2025-02-07",
    "accession_number": "0001193125-25-022808",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312525022808/d934950d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-02-06",
    "accession_number": "0000014272-25-000037",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427225000037/bmy-20250206.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-02-06",
    "accession_number": "0000059478-25-000037",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000037/lly-20250206.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-02-06",
    "accession_number": "0001110803-25-000014",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000014/ilmn-20250206.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-02-06",
    "accession_number": "0000914475-25-000034",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000034/nbix-20250206.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-02-05",
    "accession_number": "0001104659-25-009673",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465925009673/tm255474d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2025-02-04",
    "accession_number": "0000078003-25-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800325000017/pfe-20250204.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2025-02-04",
    "accession_number": "0001104659-25-008863",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465925008863/tm255059d1_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2025-02-04",
    "accession_number": "0000318154-25-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815425000005/amgn-20250204.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-02-04",
    "accession_number": "0001804220-25-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/regn-20250204.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-01-31",
    "accession_number": "0001551152-25-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000011/abbv-20250131.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-01-29",
    "accession_number": "0001104659-25-007028",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465925007028/tm254750d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2025-01-27",
    "accession_number": "0000914475-25-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447525000006/nbix-20250124.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K/A",
    "filing_date": "2025-01-22",
    "accession_number": "0000200406-25-000007",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000007/jnj-20250122.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2025-01-22",
    "accession_number": "0000200406-25-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000003/jnj-20250122.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2025-01-15",
    "accession_number": "0001193125-25-006578",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/d830064d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2025-01-14",
    "accession_number": "0000059478-25-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000005/lly-20250114.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2025-01-14",
    "accession_number": "0001110803-25-000011",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000011/ilmn-20230621.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2025-01-14",
    "accession_number": "0001110803-25-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080325000009/ilmn-20250114.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-01-14",
    "accession_number": "0001558370-25-000184",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025000184/srrk-20250114x8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001140361-25-000885",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036125000885/ef20041375_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001104659-25-002826",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465925002826/tm253014d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001682852-25-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285225000002/mrna-20250113.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001193125-25-004939",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312525004939/d925380d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001124140-25-000008",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000008/exas-20250112.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001178670-25-000008",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867025000008/alny-20250112.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001193125-25-005160",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312525005160/d900352d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001558370-25-000160",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837025000160/bpmc-20250113x8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001558370-25-000156",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837025000156/srrk-20250113x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001104659-25-002846",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465925002846/tm253044d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2025-01-13",
    "accession_number": "0001770787-25-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078725000003/txg-20250112.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-01-10",
    "accession_number": "0001551152-25-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000006/abbv-20250109.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2025-01-10",
    "accession_number": "0000879169-25-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916925000011/incy-20250106.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2025-01-06",
    "accession_number": "0001551152-25-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115225000002/abbv-20250106.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2025-01-06",
    "accession_number": "0001124140-25-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/exas-20250102.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-12-20",
    "accession_number": "0000875320-24-000231",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000231/vrtx-20241220.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-12-20",
    "accession_number": "0000914475-24-000229",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000229/nbix-20241220.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-12-20",
    "accession_number": "0001140361-24-050057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124050057/ef20040455_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-12-18",
    "accession_number": "0001558370-24-016357",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837024016357/bpmc-20241213x8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-12-17",
    "accession_number": "0000078003-24-000195",
    "description": "PFIZER 8-K DECEMBER 17, 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000195/pfe-20241217.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-12-13",
    "accession_number": "0001104659-24-128413",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924128413/tm2430950d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K/A",
    "filing_date": "2024-12-13",
    "accession_number": "0001104659-24-128088",
    "description": "FORM 8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924128088/tm2430889d1_8ka.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-12-13",
    "accession_number": "0001193125-24-278680",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312524278680/d863923d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-12-06",
    "accession_number": "0001104659-24-126348",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924126348/tm2430337d1_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2024-11-26",
    "accession_number": "0001193125-24-265627",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312524265627/d856104d8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-11-22",
    "accession_number": "0001104659-24-122027",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924122027/tm2429161d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-11-20",
    "accession_number": "0001104659-24-121025",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924121025/tm2426602d4_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-11-19",
    "accession_number": "0000059478-24-000258",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000258/lly-20241119.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-11-19",
    "accession_number": "0001628280-24-048434",
    "description": "8-K AMENDED AND RESTATED BYLAWS",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024048434/vrt-20241115.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-11-18",
    "accession_number": "0001628280-24-048175",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024048175/vrt-20241118.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-11-12",
    "accession_number": "0001558370-24-015149",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024015149/srrk-20241112x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-11-12",
    "accession_number": "0001104659-24-116777",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924116777/tm2427439d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-11-12",
    "accession_number": "0001193125-24-256070",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312524256070/d901217d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-11-07",
    "accession_number": "0001682852-24-000057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000057/mrna-20241107.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-11-06",
    "accession_number": "0000882095-24-000025",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209524000025/gild-20241106.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-11-06",
    "accession_number": "0001140361-24-045370",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124045370/ef20038192_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-11-05",
    "accession_number": "0001124140-24-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000081/exas-20241105.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-11-04",
    "accession_number": "0000875320-24-000221",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000221/vrtx-20241104.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-11-04",
    "accession_number": "0001110803-24-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000049/ilmn-20241104.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-11-01",
    "accession_number": "0000914475-24-000214",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000214/nbix-20241031.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-10-31",
    "accession_number": "0001104659-24-112841",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924112841/tm2426878d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-10-31",
    "accession_number": "0000014272-24-000145",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427224000145/bmy-20241031.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-10-31",
    "accession_number": "0001804220-24-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422024000038/regn-20241031.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-10-31",
    "accession_number": "0001193125-24-248137",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524248137/d788088d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-10-31",
    "accession_number": "0001178670-24-000052",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867024000052/alny-20241031.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0001551152-24-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000036/abbv-20241030.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0000059478-24-000242",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000242/lly-20241030.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0000318154-24-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815424000042/amgn-20241030.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0001193125-24-247628",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312524247628/d890797d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0000875045-24-000030",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504524000030/biib-20241030.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0000914475-24-000210",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000210/nbix-20241030.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-10-30",
    "accession_number": "0001558370-24-013882",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837024013882/bpmc-20241030x8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-10-29",
    "accession_number": "0000078003-24-000188",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000188/pfe-20241029.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-10-29",
    "accession_number": "0001048477-24-000149",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000149/bmrn-20241029.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-10-29",
    "accession_number": "0000879169-24-000169",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916924000169/incy-20241029.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-10-29",
    "accession_number": "0001770787-24-000071",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000071/txg-20241024.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-10-23",
    "accession_number": "0001628280-24-043343",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024043343/vrt-20241023.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-10-15",
    "accession_number": "0000078003-24-000185",
    "description": "PFIZER 8-K OCTOBER 10 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000185/pfe-20241010.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-10-15",
    "accession_number": "0000200406-24-000088",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000088/jnj-20241015.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-10-11",
    "accession_number": "0000914475-24-000206",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/nbix-20241011.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-10-10",
    "accession_number": "0001104659-24-107447",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465924107447/tm2425688d16_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-10-09",
    "accession_number": "0001770787-24-000064",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000064/txg-20241009.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-10-07",
    "accession_number": "0001104659-24-106432",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465924106432/tm2419098d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-10-07",
    "accession_number": "0001104659-24-106461",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465924106461/tm2425688d7_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-10-03",
    "accession_number": "0001551152-24-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000033/abbv-20241003.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-10-03",
    "accession_number": "0000950157-24-001364",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015724001364/form8-k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-10-02",
    "accession_number": "0001682852-24-000052",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000052/mrna-20240928.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-09-24",
    "accession_number": "0001193125-24-224139",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312524224139/d887671d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-09-20",
    "accession_number": "0000200406-24-000083",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000083/jnj-20240920.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2024-09-16",
    "accession_number": "0000950170-24-106619",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/srpt-20240912.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-09-12",
    "accession_number": "0001682852-24-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000049/mrna-20240912.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-09-12",
    "accession_number": "0001193125-24-217633",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312524217633/d896502d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-09-12",
    "accession_number": "0001193125-24-217333",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312524217333/d865048d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-09-10",
    "accession_number": "0000200406-24-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000081/jnj-20240910.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-09-10",
    "accession_number": "0001104659-24-098564",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-09-09",
    "accession_number": "0000059478-24-000213",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000213/lly-20240905.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-09-09",
    "accession_number": "0001193125-24-215883",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524215883/d888510d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-09-09",
    "accession_number": "0001193125-24-215939",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312524215939/d881331d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-09-05",
    "accession_number": "0001193125-24-214335",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524214335/d856020d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-09-04",
    "accession_number": "0001048477-24-000136",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000136/bmrn-20240828.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-09-04",
    "accession_number": "0001628280-24-039216",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024039216/vrt-20240904.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-08-28",
    "accession_number": "0001048477-24-000132",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000132/bmrn-20240823.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-08-28",
    "accession_number": "0000914475-24-000199",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000199/nbix-20240828.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-08-26",
    "accession_number": "0000200406-24-000079",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000079/jnj-20240826.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-08-22",
    "accession_number": "0001193125-24-205405",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312524205405/d880241d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-08-16",
    "accession_number": "0000059478-24-000196",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/lly-20240813.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-08-16",
    "accession_number": "0000875320-24-000207",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-08-14",
    "accession_number": "0001193125-24-200435",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312524200435/d876011d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-08-14",
    "accession_number": "0001193125-24-200660",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312524200660/d867868d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-08-08",
    "accession_number": "0000059478-24-000185",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000185/lly-20240808.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-08-08",
    "accession_number": "0000882095-24-000020",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209524000020/gild-20240808.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-08-08",
    "accession_number": "0001558370-24-011465",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024011465/srrk-20240808x8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-08-08",
    "accession_number": "0001104659-24-087273",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924087273/tm2420614d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-08-08",
    "accession_number": "0001770787-24-000058",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000058/txg-20240806.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-08-07",
    "accession_number": "0001193125-24-195400",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524195400/d813823d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2024-08-06",
    "accession_number": "0000318154-24-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815424000033/amgn-20240806.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-08-06",
    "accession_number": "0001110803-24-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000042/ilmn-20240806.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-08-05",
    "accession_number": "0001048477-24-000125",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000125/bmrn-20240805.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0001804220-24-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422024000026/regn-20240801.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0000875320-24-000193",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000193/vrtx-20240801.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0001682852-24-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000043/mrna-20240801.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0000875045-24-000022",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504524000022/biib-20240801.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0001178670-24-000039",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867024000039/alny-20240801.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0000914475-24-000180",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000180/nbix-20240801.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0001140361-24-035233",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124035233/ef20033414_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-08-01",
    "accession_number": "0001104659-24-084629",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465924084629/tm2420612d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-07-31",
    "accession_number": "0001124140-24-000067",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000067/exas-20240731.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-07-30",
    "accession_number": "0000078003-24-000155",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000155/pfe-20240730.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-07-30",
    "accession_number": "0001104659-24-083722",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924083722/tm2420272d1_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-07-30",
    "accession_number": "0000879169-24-000146",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916924000146/incy-20240730.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-07-26",
    "accession_number": "0000078003-24-000144",
    "description": "PFIZER 8-K JULY 24 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000144/pfe-20240724.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-07-26",
    "accession_number": "0000014272-24-000121",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427224000121/bmy-20240726.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-07-25",
    "accession_number": "0001551152-24-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000026/abbv-20240725.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-07-24",
    "accession_number": "0001628280-24-032675",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024032675/vrt-20240724.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-07-23",
    "accession_number": "0001682852-24-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000035/mrna-20240719.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-07-22",
    "accession_number": "0001104659-24-081215",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924081215/tm2419819d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-07-17",
    "accession_number": "0000200406-24-000071",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000071/jnj-20240717.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-07-17",
    "accession_number": "0001104659-24-080355",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924080355/tm2419649d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-07-11",
    "accession_number": "0001770787-24-000048",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000048/txg-20240710.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-07-10",
    "accession_number": "0000078003-24-000130",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/pfe-20240709.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-07-10",
    "accession_number": "0000059478-24-000164",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/lly-20240705.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-07-08",
    "accession_number": "0001104659-24-078172",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465924078172/tm2418837d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-07-03",
    "accession_number": "0001551152-24-000024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000024/abbv-20240703.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-07-03",
    "accession_number": "0001104659-24-077770",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465924077770/tm2418800d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-07-01",
    "accession_number": "0000078003-24-000127",
    "description": "8-K JUNE 27, 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/pfe-20240627.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-28",
    "accession_number": "0001558370-24-009582",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024009582/srrk-20240627x8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-06-27",
    "accession_number": "0000875320-24-000178",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000178/vrtx-20240627.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2024-06-27",
    "accession_number": "0001110803-24-000038",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000038/ilmn-20240603.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2024-06-27",
    "accession_number": "0001110803-24-000037",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000037/ilmn-20240627.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-06-27",
    "accession_number": "0001193125-24-170634",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/d839852d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-06-25",
    "accession_number": "0001193125-24-167938",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312524167938/d840763d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-06-24",
    "accession_number": "0001193125-24-167025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524167025/d851030d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-24",
    "accession_number": "0001558370-24-009419",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024009419/srrk-20240624x8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-21",
    "accession_number": "0001193125-24-165741",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312524165741/d839260d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-06-20",
    "accession_number": "0001104659-24-073372",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465924073372/tm2417559d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-06-20",
    "accession_number": "0001770787-24-000044",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000044/txg-20240618.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-06-18",
    "accession_number": "0001140361-24-030533",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124030533/ef20031337_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-06-18",
    "accession_number": "0001140361-24-030447",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124030447/ef20031301_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-06-18",
    "accession_number": "0001104659-24-072800",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924072800/tm2417454d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-06-17",
    "accession_number": "0001193125-24-162068",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524162068/d840320d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-06-17",
    "accession_number": "0001124140-24-000054",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000054/exas-20240613.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-06-14",
    "accession_number": "0000879169-24-000082",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916924000082/incy-20240612.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-06-14",
    "accession_number": "0001104659-24-071734",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465924071734/tm2417305d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-06-13",
    "accession_number": "0001770787-24-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000040/txg-20240611.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-13",
    "accession_number": "0001193125-24-160352",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312524160352/d937211d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-06-10",
    "accession_number": "0001140361-24-029588",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124029588/ef20030961_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-07",
    "accession_number": "0001193125-24-157458",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/d810236d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2024-06-06",
    "accession_number": "0001193125-24-155272",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524155272/d811905d8ka.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-06-05",
    "accession_number": "0000059478-24-000146",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000146/lly-20240602.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-04",
    "accession_number": "0001628280-24-026473",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024026473/vrt-20240604.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2024-06-03",
    "accession_number": "0001193125-24-153221",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312524153221/d827769d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-06-03",
    "accession_number": "0001193125-24-153239",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312524153239/d700243d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-06-03",
    "accession_number": "0001124140-24-000051",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000051/exas-20240530.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-06-03",
    "accession_number": "0001558370-24-008865",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024008865/srrk-20240603x8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-05-31",
    "accession_number": "0001140361-24-028247",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124028247/ef20030319_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-05-30",
    "accession_number": "0001628280-24-025800",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000162828024025800/mrk-20240528.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-05-28",
    "accession_number": "0001193125-24-148107",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000119312524148107/d836271d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-05-24",
    "accession_number": "0001193125-24-147013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312524147013/d95239d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-05-24",
    "accession_number": "0001558370-24-008619",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837024008619/bpmc-20240522x8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-05-23",
    "accession_number": "0000914475-24-000140",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/nbix-20240522.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-05-22",
    "accession_number": "0000078003-24-000113",
    "description": "8-K MAY 22, 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000113/pfe-20240522.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-05-22",
    "accession_number": "0001558370-24-008556",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024008556/srrk-20240517x8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-05-20",
    "accession_number": "0001193125-24-142828",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312524142828/d746288d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-05-20",
    "accession_number": "0001193125-24-142278",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000119312524142278/d818729d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-05-20",
    "accession_number": "0001110803-24-000030",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000030/ilmn-20240516.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-05-20",
    "accession_number": "0001178670-24-000027",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867024000027/alny-20240516.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-05-17",
    "accession_number": "0000200406-24-000053",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000053/jnj-20240517.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-05-15",
    "accession_number": "0000875320-24-000142",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000142/vrtx-20240515.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-05-14",
    "accession_number": "0001048477-24-000082",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000082/bmrn-20240509.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-05-14",
    "accession_number": "0001558370-24-008057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024008057/srrk-20240514x8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-05-13",
    "accession_number": "0001104659-24-060207",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465924060207/tm2413972d2_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-05-09",
    "accession_number": "0001140361-24-025213",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124025213/ef20028830_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-05-09",
    "accession_number": "0000059478-24-000127",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/lly-20240506.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-05-09",
    "accession_number": "0000882095-24-000016",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209524000016/gild-20240508.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-05-09",
    "accession_number": "0001682852-24-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/mrna-20240506.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-05-09",
    "accession_number": "0001104659-24-059333",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924059333/tm2413904d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K/A",
    "filing_date": "2024-05-08",
    "accession_number": "0001104659-24-058808",
    "description": "FORM 8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924058808/tm2413796d1_8ka.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-05-08",
    "accession_number": "0001124140-24-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000049/exas-20240508.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-05-08",
    "accession_number": "0001124140-24-000045",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000045/exas-20240508.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-05-07",
    "accession_number": "0001193125-24-133196",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/d815387d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-05-07",
    "accession_number": "0001193125-24-132559",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524132559/d828444d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-05-07",
    "accession_number": "0001140361-24-024648",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124024648/ef20028585_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-05-07",
    "accession_number": "0001558370-24-006906",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000155837024006906/srrk-20240507x8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-05-06",
    "accession_number": "0000875320-24-000137",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000137/vrtx-20240506.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2024-05-03",
    "accession_number": "0001110803-24-000025",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000025/form8-karestructuring5224.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0000318154-24-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815424000018/amgn-20240502.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0001804220-24-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422024000015/regn-20240502.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0001682852-24-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000023/mrna-20240502.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0001110803-24-000019",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000019/ilmn-20240502.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0001178670-24-000021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000117867024000021/alny-20240502.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-05-02",
    "accession_number": "0001558370-24-006451",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837024006451/bpmc-20240502x8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-05-01",
    "accession_number": "0000078003-24-000103",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000103/pfe-20240501.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-05-01",
    "accession_number": "0000200406-24-000048",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000048/jnj-20240501.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-05-01",
    "accession_number": "0000914475-24-000116",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000116/nbix-20240501.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-04-30",
    "accession_number": "0000059478-24-000116",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000116/lly-20240430.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-04-30",
    "accession_number": "0000879169-24-000074",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916924000074/incy-20240430.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-04-30",
    "accession_number": "0001770787-24-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000035/txg-20240430.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-04-29",
    "accession_number": "0000078003-24-000101",
    "description": "PFIZER 8-K APRIL 25 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000101/pfe-20240425.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-04-29",
    "accession_number": "0000200406-24-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000043/jnj-20240425.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-04-26",
    "accession_number": "0001551152-24-000016",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000016/abbv-20240426.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-04-25",
    "accession_number": "0001104659-24-051517",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/tm2412490d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-04-25",
    "accession_number": "0000014272-24-000094",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427224000094/bmy-20240425.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-04-25",
    "accession_number": "0000882095-24-000010",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209524000010/gild-20240425.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-04-25",
    "accession_number": "0001124140-24-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000036/exas-20240425.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-04-25",
    "accession_number": "0001104659-24-051658",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465924051658/tm2412692d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-04-24",
    "accession_number": "0000875045-24-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504524000012/biib-20240424.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-04-24",
    "accession_number": "0001048477-24-000066",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000066/bmrn-20240424.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-04-24",
    "accession_number": "0001628280-24-017513",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024017513/vrt-20240424.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-04-23",
    "accession_number": "0001193125-24-107015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312524107015/d797498d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-04-17",
    "accession_number": "0001124140-24-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000020/exas-20240417.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K/A",
    "filing_date": "2024-04-16",
    "accession_number": "0000200406-24-000036",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000036/jnj-20240416.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-04-16",
    "accession_number": "0000200406-24-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000031/jnj-20240416.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-04-15",
    "accession_number": "0001124140-24-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000015/exas-20240415.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-04-12",
    "accession_number": "0001110803-24-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000013/ilmn-20240412.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-04-11",
    "accession_number": "0001193125-24-092475",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000119312524092475/d752930d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-04-09",
    "accession_number": "0000950157-24-000591",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/form8-k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-04-08",
    "accession_number": "0001140361-24-018449",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124018449/ef20026226_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-04-04",
    "accession_number": "0001628280-24-014885",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024014885/vrt-20240329.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-04-03",
    "accession_number": "0001551152-24-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000013/abbv-20240403.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-04-02",
    "accession_number": "0001193125-24-084797",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524084797/d818318d8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-03-22",
    "accession_number": "0001104659-24-037619",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924037619/tm249475d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-03-20",
    "accession_number": "0001193125-24-072706",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524072706/d774533d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-03-19",
    "accession_number": "0001104659-24-035865",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465924035865/tm249126d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-03-18",
    "accession_number": "0001140361-24-013978",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124013978/ef20024402_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-03-18",
    "accession_number": "0001140361-24-013726",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124013726/ef20024275_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-03-15",
    "accession_number": "0001193125-24-068170",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524068170/d788116d8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-03-14",
    "accession_number": "0001104659-24-034493",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924034493/tm248821d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-03-07",
    "accession_number": "0001628280-24-009659",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024009659/vrt-20240307.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-03-04",
    "accession_number": "0001193125-24-057906",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312524057906/d746189d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-02-29",
    "accession_number": "0001140361-24-010288",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/ef20022767_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-02-28",
    "accession_number": "0001193125-24-049136",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524049136/d757603d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-02-28",
    "accession_number": "0001193125-24-049116",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524049116/d743882d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-02-28",
    "accession_number": "0001104659-24-028724",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924028724/tm247042d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-02-26",
    "accession_number": "0001104659-24-027585",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924027585/tm246405d5_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-02-22",
    "accession_number": "0001140361-24-009040",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124009040/ef20022028_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-02-22",
    "accession_number": "0001682852-24-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000010/mrna-20240222.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-02-22",
    "accession_number": "0001048477-24-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847724000013/bmrn-20240222.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-02-22",
    "accession_number": "0001104659-24-026343",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465924026343/tm246979d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-02-21",
    "accession_number": "0001124140-24-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000010/exas-20240221.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-02-21",
    "accession_number": "0001140361-24-008700",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124008700/ef20022046_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-02-21",
    "accession_number": "0001628280-24-005765",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828024005765/vrt-20240221.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-02-20",
    "accession_number": "0001104659-24-025524",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924025524/tm246758d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-02-20",
    "accession_number": "0001104659-24-025262",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2024-02-16",
    "accession_number": "0001193125-24-038556",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312524038556/d595876d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-02-15",
    "accession_number": "0001140361-24-008198",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124008198/ef20021804_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-02-15",
    "accession_number": "0001157523-24-000253",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752324000253/a53896787.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-02-15",
    "accession_number": "0001558370-24-001197",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837024001197/bpmc-20240215x8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-02-15",
    "accession_number": "0001104659-24-024369",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465924024369/tm246269d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-02-15",
    "accession_number": "0001770787-24-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000015/txg-20240215.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-02-14",
    "accession_number": "0001140361-24-008013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124008013/ef20021631_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2024-02-13",
    "accession_number": "0000875045-24-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504524000004/biib-20240213.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2024-02-13",
    "accession_number": "0000879169-24-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916924000042/incy-20240213.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-02-12",
    "accession_number": "0001104659-24-013692",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465924013692/tm245657d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-02-12",
    "accession_number": "0000950103-24-002027",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/dp206638_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-02-09",
    "accession_number": "0001193125-24-029551",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312524029551/d728700d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-02-08",
    "accession_number": "0001110803-24-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000007/ilmn-20240208.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2024-02-07",
    "accession_number": "0000914475-24-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447524000033/nbix-20240207.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2024-02-06",
    "accession_number": "0000059478-24-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000032/lly-20240206.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2024-02-06",
    "accession_number": "0000318154-24-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815424000004/amgn-202312318xk.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-02-06",
    "accession_number": "0000882095-24-000003",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209524000003/gild-20240206.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-02-05",
    "accession_number": "0000875320-24-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532024000012/vrtx-20240205.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-02-02",
    "accession_number": "0001551152-24-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/abbv-20240202.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-02-02",
    "accession_number": "0000014272-24-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427224000020/bmy-20240202.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2024-02-02",
    "accession_number": "0001104659-24-010051",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465924010051/tm244922d1_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-02-02",
    "accession_number": "0001804220-24-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422024000006/regn-20240202.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2024-02-01",
    "accession_number": "0001104659-24-009109",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465924009109/tm244517d1_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-01-31",
    "accession_number": "0001104659-24-008807",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465924008807/tm244671d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-01-30",
    "accession_number": "0000078003-24-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000017/pfe-20240130.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2024-01-23",
    "accession_number": "0000200406-24-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000004/jnj-20240123.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2024-01-22",
    "accession_number": "0001140361-24-002995",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036124002995/ef20019323_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-01-22",
    "accession_number": "0001104659-24-005384",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/tm243767d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-01-19",
    "accession_number": "0001193125-24-011278",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/d701085d8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-01-16",
    "accession_number": "0001770787-24-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/txg-20240115.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2024-01-11",
    "accession_number": "0001193125-24-006599",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312524006599/d719423d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2024-01-10",
    "accession_number": "0000078003-24-000006",
    "description": "PFIZER 8-K JANUARY 10 2024",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800324000006/pfe-20240110.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2024-01-09",
    "accession_number": "0001110803-24-000004",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000004/ilmn-20230621.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-01-09",
    "accession_number": "0001110803-24-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080324000002/ilmn-20240109.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2024-01-09",
    "accession_number": "0001104659-24-002451",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465924002451/tm242418d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001140361-24-001288",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036124001288/ef20018276_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001104659-24-002037",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465924002037/tm242296d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001682852-24-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285224000004/mrna-20240108.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001193125-24-004269",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312524004269/d669791d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001124140-24-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414024000003/exas-20240107.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001193125-24-003854",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312524003854/d34101d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0000950170-24-002822",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017024002822/srpt-20240108.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001104659-24-002075",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465924002075/tm242338d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001157523-24-000027",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752324000027/a53878319.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2024-01-08",
    "accession_number": "0001770787-24-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078724000004/txg-20240108.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2024-01-05",
    "accession_number": "0001551152-24-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115224000002/abbv-20240105.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2024-01-04",
    "accession_number": "0000950157-24-000024",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015724000024/form8-k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-12-22",
    "accession_number": "0001140361-23-059159",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123059159/ef20017313_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-12-22",
    "accession_number": "0001140361-23-058974",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123058974/ef20017247_form8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-12-20",
    "accession_number": "0001193125-23-300042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312523300042/d488420d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-12-18",
    "accession_number": "0001140361-23-058152",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123058152/ef20016866_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K/A",
    "filing_date": "2023-12-14",
    "accession_number": "0001193125-23-295562",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312523295562/d612444d8ka.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-12-14",
    "accession_number": "0001193125-23-294930",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312523294930/d553734d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-12-14",
    "accession_number": "0001193125-23-295027",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523295027/d598661d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-12-14",
    "accession_number": "0001140361-23-057644",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123057644/ef20016672_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-12-13",
    "accession_number": "0000078003-23-000120",
    "description": "8-K DECEMBER 13 2023",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000120/pfe-20231213.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-12-13",
    "accession_number": "0001193125-23-293984",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312523293984/d648019d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-12-12",
    "accession_number": "0000078003-23-000118",
    "description": "PFIZER 8-K DECEMBER 7 2023",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000118/pfe-20231207.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-12-12",
    "accession_number": "0001682852-23-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000049/mrna-20231208.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-12-12",
    "accession_number": "0001193125-23-293433",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523293433/d850833d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-12-08",
    "accession_number": "0000875320-23-000054",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000054/vrtx-20231208.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-12-06",
    "accession_number": "0001104659-23-124047",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923124047/tm2332303d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-12-05",
    "accession_number": "0000200406-23-000115",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/jnj-20231130.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-12-05",
    "accession_number": "0000200406-23-000112",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000112/jnj-20231205.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-12-05",
    "accession_number": "0000875320-23-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/vrtx-20231205.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-12-04",
    "accession_number": "0001628280-23-040528",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023040528/vrt-20231204.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-11-30",
    "accession_number": "0000200406-23-000109",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000109/jnj-20231130.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-11-30",
    "accession_number": "0001104659-23-122241",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923122241/tm2331814d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-11-29",
    "accession_number": "0000950142-23-002855",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000095014223002855/eh230424978_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-11-28",
    "accession_number": "0001104659-23-121671",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465923121671/tm2331303d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-11-27",
    "accession_number": "0000200406-23-000105",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000105/jnj-20231121.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-11-13",
    "accession_number": "0001140361-23-052908",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2023-11-13",
    "accession_number": "0001110803-23-000088",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000088/ilmn-20230621.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-11-13",
    "accession_number": "0000914475-23-000078",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000078/nbix-20231110.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-11-09",
    "accession_number": "0001110803-23-000085",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000085/ilmn-20231109.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2023-11-09",
    "accession_number": "0001110803-23-000078",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000078/ilmn-20230831.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-11-09",
    "accession_number": "0000914475-23-000075",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000075/nbix-20231109.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-11-08",
    "accession_number": "0001193125-23-273579",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523273579/d454419d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-11-08",
    "accession_number": "0000875045-23-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504523000035/biib-20231108.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-11-08",
    "accession_number": "0001104659-23-115735",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923115735/tm2329774d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-11-07",
    "accession_number": "0000882095-23-000029",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209523000029/gild-20231107.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-11-07",
    "accession_number": "0001157523-23-001660",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323001660/a53761938.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-11-06",
    "accession_number": "0000875320-23-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000029/vrtx-20231106.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-11-06",
    "accession_number": "0001682852-23-000044",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000044/mrna-20231106.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-11-06",
    "accession_number": "0001193125-23-270884",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523270884/d583670d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-11-03",
    "accession_number": "0001193125-23-270370",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312523270370/d578678d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0000059478-23-000282",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/lly-20231102.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0001804220-23-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422023000029/regn-20231102.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0001682852-23-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000038/mrna-20231102.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0001157523-23-001622",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752323001622/a53737945.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0001140361-23-051047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123051047/ef20013902_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-11-02",
    "accession_number": "0001770787-23-000051",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000051/txg-20231102.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-11-01",
    "accession_number": "0001048477-23-000041",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847723000041/bmrn-20231101.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-11-01",
    "accession_number": "0001124140-23-000088",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000088/exas-20231031.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-10-31",
    "accession_number": "0000078003-23-000111",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000111/pfe-20231031.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K/A",
    "filing_date": "2023-10-31",
    "accession_number": "0001140361-23-050518",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/ef20013739_8ka.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-10-31",
    "accession_number": "0000318154-23-000061",
    "description": "AMGN-2023.9.30 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815423000061/amgn-20231031.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-10-31",
    "accession_number": "0000879169-23-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916923000038/incy-20231031.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-10-31",
    "accession_number": "0000914475-23-000072",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000072/nbix-20231031.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-10-27",
    "accession_number": "0001551152-23-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000040/abbv-20231027.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-10-26",
    "accession_number": "0001104659-23-111585",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465923111585/tm2328962d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-10-26",
    "accession_number": "0000014272-23-000179",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427223000179/bmy-20231026.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-10-26",
    "accession_number": "0001104659-23-111596",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923111596/tm2329192d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-10-25",
    "accession_number": "0001628280-23-035032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023035032/vrt-20231025.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-10-23",
    "accession_number": "0000200406-23-000096",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000096/jnj-20231020.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2023-10-18",
    "accession_number": "0001110803-23-000069",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000069/ilmn-20230525.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-10-17",
    "accession_number": "0000200406-23-000094",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000094/jnj-20231017.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-10-16",
    "accession_number": "0001682852-23-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000033/mrna-20231016.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-10-13",
    "accession_number": "0000078003-23-000099",
    "description": "PFIZER 8-K OCTOBER 13 2023",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000099/pfe-20231013.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-10-12",
    "accession_number": "0001104659-23-108864",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-10-12",
    "accession_number": "0001104659-23-108849",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465923108849/tm2328106d2_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-10-11",
    "accession_number": "0001104659-23-108591",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465923108591/tm2328106d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-10-10",
    "accession_number": "0001193125-23-253084",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523253084/d279887d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-10-06",
    "accession_number": "0001193125-23-252361",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523252361/d534754d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-10-06",
    "accession_number": "0000914475-23-000067",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000067/nbix-20231005.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-10-05",
    "accession_number": "0001193125-23-251090",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523251090/d533762d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-10-05",
    "accession_number": "0001104659-23-107161",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923107161/tm2327767d1_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-10-05",
    "accession_number": "0000875320-23-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/vrtx-20231003.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-10-05",
    "accession_number": "0000914475-23-000065",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000065/nbix-20231005.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-10-04",
    "accession_number": "0001551152-23-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000036/abbv-20231004.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-10-02",
    "accession_number": "0001193125-23-249192",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523249192/d485845d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K/A",
    "filing_date": "2023-09-28",
    "accession_number": "0001193125-23-245816",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523245816/d534386d8ka.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-09-28",
    "accession_number": "0001193125-23-245768",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/d477237d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-09-27",
    "accession_number": "0001140361-23-045401",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123045401/ef20011349_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-09-26",
    "accession_number": "0001193125-23-242617",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523242617/d487087d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-09-26",
    "accession_number": "0001140361-23-045170",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123045170/ef20011263_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-09-25",
    "accession_number": "0001193125-23-241315",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/d684437d8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-09-14",
    "accession_number": "0001104659-23-100638",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465923100638/tm2324696d5_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-09-14",
    "accession_number": "0001193125-23-235340",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523235340/d521240d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-09-13",
    "accession_number": "0001193125-23-234395",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523234395/d444513d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-09-13",
    "accession_number": "0001193125-23-234385",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523234385/d475156d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-09-12",
    "accession_number": "0001193125-23-233011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523233011/d523167d8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-09-12",
    "accession_number": "0001104659-23-100062",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465923100062/tm2325962d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-09-12",
    "accession_number": "0000914475-23-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000062/nbix-20230912.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-09-11",
    "accession_number": "0001682852-23-000030",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000030/mrna-20230911.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K/A",
    "filing_date": "2023-09-08",
    "accession_number": "0001104659-23-099351",
    "description": "FORM 8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923099351/tm2325712d1_8ka.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-09-08",
    "accession_number": "0001104659-23-099345",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/tm2325712d2_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-09-08",
    "accession_number": "0001110803-23-000067",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000067/ilmn-20230905.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-09-07",
    "accession_number": "0001104659-23-098990",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923098990/tm2325238d4_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-09-05",
    "accession_number": "0001193125-23-228161",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523228161/d449681d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-09-05",
    "accession_number": "0000950157-23-000929",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015723000929/form8-k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-09-01",
    "accession_number": "0001193125-23-227040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/d525571d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-09-01",
    "accession_number": "0001193125-23-227692",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523227692/d540978d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-08-30",
    "accession_number": "0000200406-23-000091",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000091/jnj-20230830.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-08-25",
    "accession_number": "0000200406-23-000086",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000086/jnj-20230823.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-08-25",
    "accession_number": "0001104659-23-095123",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923095123/tm2324821d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-23",
    "accession_number": "0001140361-23-041038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123041038/brhc20057911_form8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-22",
    "accession_number": "0001140361-23-040746",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123040746/brhc20057833_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-08-16",
    "accession_number": "0001104659-23-092665",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465923092665/tm2323971d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-08-10",
    "accession_number": "0001140361-23-038900",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123038900/brhc20057302_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-08-09",
    "accession_number": "0001110803-23-000061",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000061/ilmn-20230807.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-08-09",
    "accession_number": "0001110803-23-000060",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000060/ilmn-20230809.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-09",
    "accession_number": "0001140361-23-038715",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123038715/brhc20057227_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-08-09",
    "accession_number": "0001157523-23-001305",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323001305/a53519737.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-08-09",
    "accession_number": "0001193125-23-207334",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312523207334/d689086d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-08-08",
    "accession_number": "0000059478-23-000219",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000219/lly-20230808.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-08-08",
    "accession_number": "0001193125-23-205600",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523205600/d542332d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-08-04",
    "accession_number": "0001193125-23-203033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523203033/d525761d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-04",
    "accession_number": "0001140361-23-038087",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123038087/brhc20056999_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0000318154-23-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815423000049/amgn-20230803.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0000882095-23-000022",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209523000022/gild-20230803.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001804220-23-000021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422023000021/regn-20230803.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001682852-23-000025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000025/mrna-20230803.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001193125-23-202313",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523202313/d472276d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001140361-23-037887",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123037887/brhc20056974_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001104659-23-087265",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923087265/tm2322356d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-08-03",
    "accession_number": "0001770787-23-000045",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000045/txg-20230803.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-08-02",
    "accession_number": "0001104659-23-086576",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923086576/tm2322643d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-08-02",
    "accession_number": "0001628280-23-026549",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023026549/vrt-20230802.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0000078003-23-000085",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000085/pfe-20230801.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0001104659-23-086030",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465923086030/tm2322190d1_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0000875320-23-000019",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000019/vrtx-20230801.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0000879169-23-000022",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916923000022/incy-20230801.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0001124140-23-000078",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000078/exas-20230801.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-08-01",
    "accession_number": "0000914475-23-000056",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000056/nbix-20230801.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-07-31",
    "accession_number": "0001193125-23-198542",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-07-31",
    "accession_number": "0001048477-23-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847723000026/bmrn-20230731.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-07-28",
    "accession_number": "0001628280-23-026095",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000162828023026095/jnj-20230728.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-07-28",
    "accession_number": "0001193125-23-196808",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523196808/d507671d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-07-27",
    "accession_number": "0000078003-23-000081",
    "description": "PFIZER IN 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000081/pfe-20230721.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-07-27",
    "accession_number": "0001551152-23-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000028/abbv-20230727.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-07-27",
    "accession_number": "0000014272-23-000150",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427223000150/bmy-20230727.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-07-26",
    "accession_number": "0001193125-23-194715",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523194715/d448801d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-07-25",
    "accession_number": "0000875045-23-000027",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504523000027/biib-20230725.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-07-24",
    "accession_number": "0001628280-23-025388",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000162828023025388/jnj-20230724.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-07-20",
    "accession_number": "0000200406-23-000073",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000073/jnj-20230720.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-07-20",
    "accession_number": "0001770787-23-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000038/txg-20230718.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2023-07-18",
    "accession_number": "0001110803-23-000054",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000054/ilmn-20230608.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-07-17",
    "accession_number": "0001193125-23-187698",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523187698/d508608d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-07-13",
    "accession_number": "0000914475-23-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000049/nbix-20230710.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-07-12",
    "accession_number": "0000914475-23-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000047/nbix-20230711.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-07-10",
    "accession_number": "0001140361-23-033840",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123033840/brhc20055702_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-07-06",
    "accession_number": "0001551152-23-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000026/abbv-20230706.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-06-30",
    "accession_number": "0001193125-23-179440",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523179440/d502542d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-06-30",
    "accession_number": "0001193125-23-179631",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523179631/d442654d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-06-30",
    "accession_number": "0001104659-23-076594",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923076594/tm2320288d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-30",
    "accession_number": "0001157523-23-001060",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323001060/a53438186.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-06-29",
    "accession_number": "0001104659-23-076373",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923076373/tm2320134d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-06-29",
    "accession_number": "0000875045-23-000024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/biib-20230626.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-06-27",
    "accession_number": "0001104659-23-075235",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923075235/tm2319791d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K/A",
    "filing_date": "2023-06-27",
    "accession_number": "0001628280-23-023607",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023023607/vrt-20230622.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-06-26",
    "accession_number": "0001110803-23-000048",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000048/ilmn-20230621.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-23",
    "accession_number": "0001193125-23-173872",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312523173872/d355125d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-22",
    "accession_number": "0000950170-23-029438",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017023029438/srpt-20230622.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-22",
    "accession_number": "0000950170-23-029354",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017023029354/srpt-20230622.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-22",
    "accession_number": "0001104659-23-073782",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465923073782/tm2319367d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-06-21",
    "accession_number": "0001124140-23-000061",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000061/exas-20230621.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-06-20",
    "accession_number": "0001193125-23-169190",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523169190/d480541d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-06-20",
    "accession_number": "0001193125-23-169187",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523169187/d521638d8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-06-16",
    "accession_number": "0001770787-23-000034",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000034/txg-20230614.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-06-15",
    "accession_number": "0001104659-23-071561",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465923071561/tm2318718d1_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-06-15",
    "accession_number": "0001104659-23-071619",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923071619/tm2318803d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-15",
    "accession_number": "0001628280-23-022231",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023022231/vrt-20230614.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-06-14",
    "accession_number": "0001104659-23-071187",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923071187/tm2318622d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-06-13",
    "accession_number": "0000950157-23-000666",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015723000666/form8-k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-06-12",
    "accession_number": "0001124140-23-000054",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000054/exas-20230608.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-06-12",
    "accession_number": "0001193125-23-165273",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312523165273/d511748d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2023-06-09",
    "accession_number": "0000950170-23-027276",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017023027276/srpt-20230608.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-06-07",
    "accession_number": "0001110803-23-000046",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000046/ilmn-20230601.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-06-06",
    "accession_number": "0001193125-23-161613",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312523161613/d501696d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-06-05",
    "accession_number": "0001193125-23-160316",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523160316/d504329d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-06-05",
    "accession_number": "0001140361-23-028261",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123028261/brhc20054000_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-05-30",
    "accession_number": "0000950157-23-000590",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015723000590/form8-k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-05-30",
    "accession_number": "0001193125-23-156584",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312523156584/d476134d8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-05-26",
    "accession_number": "0001140361-23-026845",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000114036123026845/brhc20053532_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-05-25",
    "accession_number": "0000950157-23-000577",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015723000577/form8-k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-05-25",
    "accession_number": "0001104659-23-064663",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923064663/tm2316983d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-05-24",
    "accession_number": "0000950142-23-001527",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000095014223001527/eh230362044_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-05-23",
    "accession_number": "0001193125-23-151845",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523151845/d689062d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-05-22",
    "accession_number": "0001193125-23-150659",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523150659/d483298d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-05-22",
    "accession_number": "0001104659-23-063202",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923063202/tm2316465d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-05-19",
    "accession_number": "0001193125-23-149364",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312523149364/d414076d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-05-19",
    "accession_number": "0001193125-23-149520",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000119312523149520/d494976d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-05-18",
    "accession_number": "0001193125-23-147662",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523147662/d499865d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-05-18",
    "accession_number": "0000875320-23-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000015/vrtx-20230517.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-05-17",
    "accession_number": "0001193125-23-147049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000119312523147049/d436124d8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-05-17",
    "accession_number": "0001770787-23-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000031/txg-20230517.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-05-16",
    "accession_number": "0001193125-23-146219",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523146219/d503983d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-05-15",
    "accession_number": "0001193125-23-144089",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312523144089/d474141d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-05-10",
    "accession_number": "0001104659-23-058520",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923058520/tm2315162d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-05-09",
    "accession_number": "0001193125-23-138953",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/d416547d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-05-09",
    "accession_number": "0001193125-23-138931",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523138931/d398921d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-05-09",
    "accession_number": "0001124140-23-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000042/exas-20230509.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-05-09",
    "accession_number": "0001157523-23-000777",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323000777/a53395784.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-05-09",
    "accession_number": "0001104659-23-057710",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923057710/tm2314862d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-05-08",
    "accession_number": "0001193125-23-138287",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312523138287/d301195d8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-05-08",
    "accession_number": "0001104659-23-057267",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465923057267/tm2315067d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-05-05",
    "accession_number": "0000882095-23-000019",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209523000019/gild-20230503.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-05-05",
    "accession_number": "0001193125-23-137079",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312523137079/d415922d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0001140361-23-022991",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123022991/brhc20052456_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0000059478-23-000165",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000165/lly-20230501.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0001804220-23-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422023000015/regn-20230504.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0001682852-23-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000018/mrna-20230504.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0001157523-23-000728",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752323000728/a53393280.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-05-04",
    "accession_number": "0001104659-23-055774",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923055774/tm2314611d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-05-03",
    "accession_number": "0001193125-23-133476",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523133476/d286559d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-05-03",
    "accession_number": "0000914475-23-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000043/nbix-20230503.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-05-03",
    "accession_number": "0001140361-23-022621",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123022621/brhc20052344_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-05-03",
    "accession_number": "0001770787-23-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000026/txg-20230503.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-05-02",
    "accession_number": "0001628280-23-014759",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000162828023014759/pfe-20230502.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-05-02",
    "accession_number": "0000879169-23-000014",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916923000014/incy-20230502.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-05-01",
    "accession_number": "0001628280-23-014368",
    "description": "8-K APRIL 27 2023",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000162828023014368/pfe-20230427.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-05-01",
    "accession_number": "0000200406-23-000059",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000059/jnj-20230427.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-05-01",
    "accession_number": "0000875320-23-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000010/vrtx-20230501.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0001104659-23-050654",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465923050654/tm2313695d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0001551152-23-000019",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000019/abbv-20230427.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0000014272-23-000102",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427223000102/bmy-20230427.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0000059478-23-000160",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/lly-20230427.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0000318154-23-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815423000026/amgn-20230427.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-04-27",
    "accession_number": "0000882095-23-000014",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209523000014/gild-20230427.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-04-26",
    "accession_number": "0001140361-23-020605",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123020605/brhc20052030_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-04-26",
    "accession_number": "0001048477-23-000016",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847723000016/bmrn-20230426.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-04-26",
    "accession_number": "0001140361-23-020335",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123020335/brhc20051944_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-04-26",
    "accession_number": "0001628280-23-013042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023013042/vrt-20230426.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-04-25",
    "accession_number": "0000875045-23-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504523000012/biib-20230425.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-04-25",
    "accession_number": "0001110803-23-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000028/ilmn-20230425.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-04-24",
    "accession_number": "0001140361-23-019757",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123019757/brhc20051808_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-04-24",
    "accession_number": "0000950142-23-001182",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000095014223001182/eh230352360_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-04-21",
    "accession_number": "0001104659-23-048356",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923048356/tm2313396d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-04-18",
    "accession_number": "0000200406-23-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000043/jnj-20230418.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-04-18",
    "accession_number": "0001193125-23-105074",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523105074/d500907d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-04-17",
    "accession_number": "0001104659-23-045897",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923045897/tm2312956d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-04-14",
    "accession_number": "0000950142-23-001087",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000095014223001087/eh230348626_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-04-10",
    "accession_number": "0001104659-23-043287",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923043287/tm2312136d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-04-10",
    "accession_number": "0001157523-23-000532",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/a53377626.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-04-05",
    "accession_number": "0001551152-23-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000015/abbv-20230405.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-04-04",
    "accession_number": "0000200406-23-000037",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000037/jnj-20230404.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-04-03",
    "accession_number": "0000200406-23-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000032/jnj-20230331.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-03-29",
    "accession_number": "0001104659-23-038299",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923038299/tm2310647d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-03-29",
    "accession_number": "0000914475-23-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000023/nbix-20230328.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-03-28",
    "accession_number": "0001104659-23-037749",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923037749/tm2310687d1_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-03-28",
    "accession_number": "0001104659-23-037774",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923037774/tm2310790d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-03-27",
    "accession_number": "0001140361-23-013852",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123013852/brhc10050366_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-03-17",
    "accession_number": "0000059478-23-000118",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000118/lly-20230317.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-03-17",
    "accession_number": "0001124140-23-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000036/exas-20230317.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-03-13",
    "accession_number": "0001193125-23-068538",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312523068538/d408093d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-03-13",
    "accession_number": "0001104659-23-031340",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465923031340/tm239207d1_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-03-13",
    "accession_number": "0001104659-23-031367",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923031367/tm239248d1_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-03-09",
    "accession_number": "0001193125-23-066144",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523066144/d466407d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-03-09",
    "accession_number": "0001193125-23-064961",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312523064961/d446055d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-03-08",
    "accession_number": "0001193125-23-064580",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523064580/d481911d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-03-07",
    "accession_number": "0001157523-23-000400",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323000400/a53357191.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-03-03",
    "accession_number": "0001124140-23-000022",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000022/exas-20230302.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2023-03-03",
    "accession_number": "0001193125-23-058990",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-03-02",
    "accession_number": "0001193125-23-058235",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523058235/d448346d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-03-01",
    "accession_number": "0001124140-23-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000017/exas-20230223.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-02-28",
    "accession_number": "0001140361-23-009050",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123009050/brhc10048710_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-02-28",
    "accession_number": "0001104659-23-026715",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923026715/tm238033d1_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-02-27",
    "accession_number": "0001048477-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847723000005/bmrn-20230227.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-02-27",
    "accession_number": "0001104659-23-025682",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923025682/tm237913d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-02-24",
    "accession_number": "0001193125-23-048910",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312523048910/d575646d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-02-24",
    "accession_number": "0000914475-23-000016",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000016/nbix-20230221.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-02-23",
    "accession_number": "0001682852-23-000008",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000008/mrna-20230223.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-02-23",
    "accession_number": "0001193125-23-045671",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523045671/d449135d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-02-23",
    "accession_number": "0001157523-23-000344",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752323000344/a53337940.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-02-23",
    "accession_number": "0001104659-23-024756",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923024756/tm237655d1_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2023-02-23",
    "accession_number": "0001104659-23-024599",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465923024599/tm235197d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-02-22",
    "accession_number": "0001140361-23-007944",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123007944/brhc10048570_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-02-22",
    "accession_number": "0001628280-23-004432",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023004432/vrt-20230222.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-02-21",
    "accession_number": "0000078003-23-000019",
    "description": "PFIZER 8-K FEB 21 2023",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000019/pfe-20230221.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-02-21",
    "accession_number": "0001124140-23-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000012/exas-20230221.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-02-16",
    "accession_number": "0001193125-23-040753",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312523040753/d424593d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-02-16",
    "accession_number": "0001104659-23-022618",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923022618/tm237061d1_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K/A",
    "filing_date": "2023-02-15",
    "accession_number": "0000200406-23-000011",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000011/jnj-20230214.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2023-02-15",
    "accession_number": "0000875045-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504523000005/biib-20230215.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2023-02-15",
    "accession_number": "0001770787-23-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078723000006/txg-20230215.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-02-14",
    "accession_number": "0000200406-23-000008",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000008/jnj-20230214.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-02-10",
    "accession_number": "0000914475-23-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000013/nbix-20230210.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-02-10",
    "accession_number": "0001104659-23-017984",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923017984/tm236270d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-02-09",
    "accession_number": "0001551152-23-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000006/abbv-20230209.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-02-09",
    "accession_number": "0001193125-23-030281",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523030281/d457771d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-02-07",
    "accession_number": "0000875320-23-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532023000004/vrtx-20230207.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-02-07",
    "accession_number": "0001110803-23-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000017/ilmn-20230207.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-02-07",
    "accession_number": "0001110803-23-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000013/ilmn-20230201.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2023-02-07",
    "accession_number": "0000879169-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916923000005/incy-20230207.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-02-06",
    "accession_number": "0001104659-23-011167",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465923011167/tm235492d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-02-06",
    "accession_number": "0000914475-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000005/nbix-20230206.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-02-03",
    "accession_number": "0001804220-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422023000005/regn-20230203.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2023-02-02",
    "accession_number": "0001104659-23-009552",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465923009552/tm235007d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-02-02",
    "accession_number": "0000014272-23-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/bmy-20230202.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2023-02-02",
    "accession_number": "0000059478-23-000025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000025/lly-20230202.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2023-02-02",
    "accession_number": "0000882095-23-000003",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209523000003/gild-20230202.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-02-01",
    "accession_number": "0001110803-23-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000006/ilmn-20230131.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2023-01-31",
    "accession_number": "0000078003-23-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800323000004/pfe-20230131.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-01-31",
    "accession_number": "0001140361-23-003577",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123003577/brhc10047309_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2023-01-31",
    "accession_number": "0000318154-23-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815423000011/amgn-20230130.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2023-01-24",
    "accession_number": "0000200406-23-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040623000005/jnj-20230124.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-01-11",
    "accession_number": "0001110803-23-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080323000003/ilmn-20230109.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2023-01-11",
    "accession_number": "0001193125-23-006489",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312523006489/d405652d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-01-10",
    "accession_number": "0001104659-23-002452",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465923002452/tm232769d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2023-01-10",
    "accession_number": "0001193125-23-005674",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312523005674/d436279d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001140361-23-000970",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036123000970/brhc10046308_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001104659-23-002091",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465923002091/tm231703d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001682852-23-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000004/mrna-20230109.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001124140-23-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414023000004/exas-20230108.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001193125-23-004109",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523004109/d424918d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0000914475-23-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447523000003/nbix-20230108.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0000950170-23-000495",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017023000495/srpt-20230109.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001140361-23-000929",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036123000929/brhc10046438_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001104659-23-002083",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923002083/tm232336d2_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2023-01-09",
    "accession_number": "0001157523-23-000029",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752323000029/a53178569.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2023-01-06",
    "accession_number": "0001551152-23-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115223000004/abbv-20230106.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2023-01-06",
    "accession_number": "0001193125-23-003554",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523003554/d426017d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2023-01-06",
    "accession_number": "0001104659-23-001876",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465923001876/tm232336d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2023-01-04",
    "accession_number": "0001193125-23-001536",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312523001536/d443370d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2023-01-03",
    "accession_number": "0001682852-23-000002",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285223000002/mrna-20230103.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2023-01-03",
    "accession_number": "0001628280-23-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828023000006/vrt-20230101.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-12-30",
    "accession_number": "0001124140-22-000074",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000074/exas-20221230.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-12-27",
    "accession_number": "0001104659-22-130188",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922130188/tm2233493d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-12-23",
    "accession_number": "0001193125-22-311537",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522311537/d434336d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-12-22",
    "accession_number": "0001193125-22-311072",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312522311072/d428734d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-12-22",
    "accession_number": "0001193125-22-311112",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522311112/d429654d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-12-21",
    "accession_number": "0001193125-22-310054",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312522310054/d440213d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-12-20",
    "accession_number": "0001104659-22-128613",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922128613/tm2233051d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-12-19",
    "accession_number": "0001193125-22-307935",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522307935/d423141d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-12-13",
    "accession_number": "0000078003-22-000107",
    "description": "PFIZER INC 8-K DECEMBER 9, 2022",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000107/pfe-20221209.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-12-13",
    "accession_number": "0000059478-22-000277",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000277/lly-20221213.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-12-13",
    "accession_number": "0001682852-22-000055",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000055/mrna-20221213.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-12-13",
    "accession_number": "0001193125-22-303832",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522303832/d384400d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-12-13",
    "accession_number": "0001193125-22-303900",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312522303900/d424180d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-12-12",
    "accession_number": "0001193125-22-302256",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522302256/d346985d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-12-06",
    "accession_number": "0001104659-22-124884",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922124884/tm2231954d1_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-12-02",
    "accession_number": "0001193125-22-297131",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522297131/d424230d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-12-01",
    "accession_number": "0000200406-22-000089",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000089/jnj-20221130.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-12-01",
    "accession_number": "0001193125-22-296685",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522296685/d424977d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-11-29",
    "accession_number": "0001104659-22-122661",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/tm2231449d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-11-21",
    "accession_number": "0001193125-22-289475",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312522289475/d356491d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-11-18",
    "accession_number": "0001628280-22-030445",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022030445/vrt-20221118.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-11-16",
    "accession_number": "0001104659-22-119581",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922119581/tm2230578d8_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-11-14",
    "accession_number": "0001193125-22-284674",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522284674/d351786d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-11-14",
    "accession_number": "0001140361-22-041132",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122041132/brhc10044032_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-11-14",
    "accession_number": "0001157523-22-001608",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322001608/a52967670.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-11-10",
    "accession_number": "0001193125-22-281950",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312522281950/d419645d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-11-09",
    "accession_number": "0001140361-22-040624",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122040624/brhc10043925_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-11-09",
    "accession_number": "0001157523-22-001571",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/a52964704.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-11-08",
    "accession_number": "0001104659-22-115934",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922115934/tm2229989d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-11-04",
    "accession_number": "0001140361-22-039934",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122039934/brhc10043749_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0000318154-22-000053",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815422000053/amgn-20221103.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0001804220-22-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422022000029/regn-20221103.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0001682852-22-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000049/mrna-20221103.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0001110803-22-000045",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000045/ilmn-20221103.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0001193125-22-276424",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522276424/d409333d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-11-03",
    "accession_number": "0001124140-22-000069",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000069/exas-20221103x8xk.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-11-02",
    "accession_number": "0001193125-22-275897",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/d393292d8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-11-02",
    "accession_number": "0001770787-22-000053",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000053/txg-20221102.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0000078003-22-000098",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000098/pfe-20221101.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0001193125-22-274491",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312522274491/d395813d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0000059478-22-000248",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000248/lly-20221101.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0000879169-22-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000087916922000007/incy-20221101.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0000914475-22-000055",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000055/nbix-20221101.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-11-01",
    "accession_number": "0001104659-22-113205",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922113205/tm2229352d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K/A",
    "filing_date": "2022-10-31",
    "accession_number": "0001628280-22-027341",
    "description": "8-K/A AMENDMENT FOR INLINE XBRL",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022027341/vrt-20221026.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-10-28",
    "accession_number": "0001551152-22-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000038/abbv-20221028.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-10-27",
    "accession_number": "0001104659-22-111729",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465922111729/tm2227726d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-10-27",
    "accession_number": "0000882095-22-000022",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209522000022/gild-20221027.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-10-27",
    "accession_number": "0000875320-22-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000036/vrtx-20221027.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-10-27",
    "accession_number": "0001157523-22-001411",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752322001411/a52953758.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-10-26",
    "accession_number": "0000014272-22-000194",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427222000194/bmy-20221025.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-10-26",
    "accession_number": "0001048477-22-000030",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000030/bmrn-20221026.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-10-26",
    "accession_number": "0001628280-22-027015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022027015/q320228-kvrt.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-10-25",
    "accession_number": "0000875045-22-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504522000028/biib-20221025.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-10-24",
    "accession_number": "0001140361-22-038198",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122038198/brhc10043182_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-10-20",
    "accession_number": "0001193125-22-265755",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522265755/d414605d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-10-18",
    "accession_number": "0000200406-22-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000081/jnj-20221018.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-10-17",
    "accession_number": "0001104659-22-109061",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922109061/tm2228315d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-10-14",
    "accession_number": "0001104659-22-108910",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922108910/tm2228135d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-10-12",
    "accession_number": "0000059478-22-000233",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000233/lly-20221012.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-10-12",
    "accession_number": "0001140361-22-036895",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122036895/brhc10042856_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-10-07",
    "accession_number": "0001193125-22-259009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312522259009/d383407d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-10-06",
    "accession_number": "0001193125-22-258375",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522258375/d341031d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-10-05",
    "accession_number": "0001551152-22-000034",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000034/abbv-20221005.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-10-04",
    "accession_number": "0001104659-22-105577",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465922105577/tm2227007d1_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-10-03",
    "accession_number": "0001104659-22-104901",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/tm2227120d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-10-03",
    "accession_number": "0001193125-22-256141",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312522256141/d403442d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-09-30",
    "accession_number": "0001193125-22-255525",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522255525/d404694d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-09-29",
    "accession_number": "0001682852-22-000045",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/mrna-20220929.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-09-23",
    "accession_number": "0001104659-22-102734",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922102734/tm2226591d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-09-20",
    "accession_number": "0001104659-22-101344",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465922101344/tm2226156d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-09-20",
    "accession_number": "0001193125-22-247717",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312522247717/d347490d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-09-19",
    "accession_number": "0001193125-22-247130",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312522247130/d357082d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-09-16",
    "accession_number": "0001193125-22-246438",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522246438/d335619d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-09-16",
    "accession_number": "0001193125-22-246487",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522246487/d386201d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-09-14",
    "accession_number": "0000200406-22-000076",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000076/jnj-20220914.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-09-13",
    "accession_number": "0001193125-22-243702",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522243702/d397120d8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-09-12",
    "accession_number": "0001104659-22-099101",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922099101/tm2225634d1_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-09-12",
    "accession_number": "0001193125-22-242460",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312522242460/d306559d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-09-07",
    "accession_number": "0001104659-22-098213",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922098213/tm2225317d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-09-06",
    "accession_number": "0000950157-22-000997",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015722000997/form8-k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-08-30",
    "accession_number": "0000914475-22-000050",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000050/nbix-20220830.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-08-24",
    "accession_number": "0001193125-22-228534",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522228534/d335044d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-08-18",
    "accession_number": "0001193125-22-224115",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522224115/d280175d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-08-17",
    "accession_number": "0001193125-22-223286",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312522223286/d390105d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-08-17",
    "accession_number": "0001104659-22-092002",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922092002/tm2223609d1_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-08-15",
    "accession_number": "0001104659-22-091194",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922091194/tm2223160d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-08-11",
    "accession_number": "0001110803-22-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000040/ilmn-20220811.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-08-09",
    "accession_number": "0001140361-22-028849",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122028849/brhc10040582_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-08-08",
    "accession_number": "0001157523-22-001073",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322001073/a52805172.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-08-08",
    "accession_number": "0001770787-22-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000047/txg-20220808.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-08-08",
    "accession_number": "0001628280-22-021416",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022021416/vrt-20220808.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-08-05",
    "accession_number": "0001628280-22-021211",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022021211/vrt-20220802.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0000059478-22-000194",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000194/lly-20220804.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0000318154-22-000039",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815422000039/amgn-20220804.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0001193125-22-211860",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522211860/d346334d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0000875320-22-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000026/vrtx-20220804.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0001193125-22-211760",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522211760/d370174d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0000914475-22-000043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000043/nbix-20220804.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-08-04",
    "accession_number": "0001104659-22-086135",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922086135/tm2222580d1_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001193125-22-211269",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/d386700d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001804220-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422022000020/regn-20220803.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001682852-22-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000040/mrna-20220803.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001048477-22-000025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000025/bmrn-20220803.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001770787-22-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000040/txg-20220803.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-08-03",
    "accession_number": "0001628280-22-020319",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022020319/vrt-20220803.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-08-02",
    "accession_number": "0000882095-22-000016",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209522000016/gild-20220802.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-08-02",
    "accession_number": "0001558370-22-011546",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000155837022011546/incy-20220802x8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-08-02",
    "accession_number": "0001124140-22-000059",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000059/exas-20220802.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-08-02",
    "accession_number": "0001104659-22-084972",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922084972/tm2222337d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-07-29",
    "accession_number": "0001551152-22-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000026/abbv-20220729.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-07-28",
    "accession_number": "0000078003-22-000091",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000091/pfe-20220728.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-07-28",
    "accession_number": "0001104659-22-083410",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465922083410/tm2221828d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-07-28",
    "accession_number": "0001104659-22-083642",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922083642/tm2221879d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-07-28",
    "accession_number": "0001157523-22-000945",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752322000945/a52793912.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-28",
    "accession_number": "0001140361-22-027187",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122027187/brhc10040095_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-07-27",
    "accession_number": "0000014272-22-000164",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427222000164/bmy-20220727.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-07-26",
    "accession_number": "0001104659-22-082822",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465922082822/tm2221808d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K/A",
    "filing_date": "2022-07-20",
    "accession_number": "0000875045-22-000023",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504522000023/biib-20220720.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-07-20",
    "accession_number": "0000875045-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504522000020/biib-20220720.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-07-19",
    "accession_number": "0000200406-22-000063",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000063/jnj-20220719.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-19",
    "accession_number": "0001140361-22-026294",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122026294/brhc10039775_form8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-18",
    "accession_number": "0001140361-22-026165",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122026165/brhc10039716_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-07-14",
    "accession_number": "0001110803-22-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000035/ilmn-20220714.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-07-14",
    "accession_number": "0001770787-22-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000036/txg-20220712.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-11",
    "accession_number": "0000875320-22-000022",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000022/vrtx-20220709.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-11",
    "accession_number": "0001140361-22-025669",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122025669/brhc10039557_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-07-06",
    "accession_number": "0001551152-22-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000023/abbv-20220706.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-07-05",
    "accession_number": "0000875320-22-000019",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/vrtx-20220701.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-06-30",
    "accession_number": "0001124140-22-000050",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000050/exas-20220629.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-06-30",
    "accession_number": "0001104659-22-076292",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922076292/tm2220123d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-06-29",
    "accession_number": "0001104659-22-075519",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922075519/tm2219873d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-06-28",
    "accession_number": "0001104659-22-075039",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922075039/tm2219549d1_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-06-27",
    "accession_number": "0001104659-22-074754",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922074754/tm2219327d2_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-06-23",
    "accession_number": "0001104659-22-073923",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922073923/tm2219327d1_8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-06-21",
    "accession_number": "0001193125-22-177791",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312522177791/d367101d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-06-21",
    "accession_number": "0001140361-22-023541",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122023541/brhc10038943_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-06-21",
    "accession_number": "0001104659-22-073069",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465922073069/tm2218966d1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-06-17",
    "accession_number": "0001193125-22-176256",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522176256/d318244d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-06-17",
    "accession_number": "0001104659-22-072136",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465922072136/tm2218780d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-06-17",
    "accession_number": "0001770787-22-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000032/txg-20220615.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-06-17",
    "accession_number": "0001628280-22-017441",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022017441/vrt-20220615.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-06-16",
    "accession_number": "0001104659-22-071867",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465922071867/tm2218646d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-06-15",
    "accession_number": "0001140361-22-023069",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122023069/brhc10038705_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-06-15",
    "accession_number": "0001104659-22-071446",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922071446/tm2218439d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-06-15",
    "accession_number": "0001628280-22-017243",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022017243/vrt-20220615.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-06-14",
    "accession_number": "0001193125-22-173444",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522173444/d518443d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-06-10",
    "accession_number": "0001124140-22-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000042/exas-20220609.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-06-09",
    "accession_number": "0001193125-22-171059",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312522171059/d340997d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-06-09",
    "accession_number": "0001104659-22-069501",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922069501/tm2218055d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-06-06",
    "accession_number": "0001140361-22-022009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122022009/brhc10038514_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-06-03",
    "accession_number": "0000950170-22-011164",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017022011164/srpt-20220602.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-06-02",
    "accession_number": "0001104659-22-067375",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922067375/tm2217255d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K/A",
    "filing_date": "2022-06-01",
    "accession_number": "0001193125-22-165220",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312522165220/d364287d8ka.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-06-01",
    "accession_number": "0000914475-22-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000035/nbix-20220531.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-06-01",
    "accession_number": "0001104659-22-067171",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922067171/tm2217229d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-05-31",
    "accession_number": "0001104659-22-066521",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922066521/tm2217146d1_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-05-31",
    "accession_number": "0001193125-22-163800",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312522163800/d356349d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-05-27",
    "accession_number": "0001110803-22-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000033/ilmn-20220526.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-05-27",
    "accession_number": "0001104659-22-065942",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465922065942/tm2217164d1_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-05-26",
    "accession_number": "0000310158-22-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000015/mrk-20220524.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-05-25",
    "accession_number": "0000914475-22-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000032/nbix-20220524.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-05-24",
    "accession_number": "0001682852-22-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000033/mrna-20220524.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-05-23",
    "accession_number": "0000875320-22-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000017/vrtx-20220523.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-05-23",
    "accession_number": "0001193125-22-157503",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522157503/d362069d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-05-23",
    "accession_number": "0000914475-22-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000028/nbix-20220518.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-05-18",
    "accession_number": "0001193125-22-154061",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522154061/d317911d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-05-18",
    "accession_number": "0001193125-22-154021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/d272923d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-05-16",
    "accession_number": "0001157523-22-000638",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322000638/a52719952.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K/A",
    "filing_date": "2022-05-13",
    "accession_number": "0001682852-22-000029",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000029/mrna-20220510.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-05-11",
    "accession_number": "0001104659-22-058862",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922058862/tm2215079d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-05-11",
    "accession_number": "0001193125-22-146929",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312522146929/d315485d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-05-10",
    "accession_number": "0001193125-22-145661",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312522145661/d336582d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-05-09",
    "accession_number": "0001193125-22-144506",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522144506/d302971d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-05-09",
    "accession_number": "0001193125-22-144230",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522144230/d293192d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-05-06",
    "accession_number": "0000059478-22-000143",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/lly-20220502.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-05-06",
    "accession_number": "0001110803-22-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000026/ilmn-20220506.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0001140361-22-017866",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122017866/brhc10037222_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0001104659-22-056435",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922056435/tm2213708d1_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0000875320-22-000011",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000011/vrtx-20220505.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0001110803-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000020/ilmn-20220505.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0001048477-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000020/bmrn-20220505.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-05-05",
    "accession_number": "0001104659-22-056451",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922056451/tm2214592d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0000059478-22-000138",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000138/lly-20220502.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0001804220-22-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422022000013/regn-20220504.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0001682852-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000020/mrna-20220504.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0000914475-22-000021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000021/nbix-20220504.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0001140361-22-017616",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122017616/brhc10037176_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-05-04",
    "accession_number": "0001770787-22-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000026/txg-20220504.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-05-03",
    "accession_number": "0000078003-22-000068",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000068/pfe-20220503.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-05-03",
    "accession_number": "0001682852-22-000016",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000016/mrna-20220428.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-05-03",
    "accession_number": "0000875045-22-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504522000013/biib-20220503.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-05-03",
    "accession_number": "0001558370-22-006719",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000155837022006719/incy-20220503x8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-05-03",
    "accession_number": "0001104659-22-055023",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922055023/tm2213933d2_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-05-02",
    "accession_number": "0000078003-22-000066",
    "description": "PFIZER 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000066/pfe-20220428.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-05-02",
    "accession_number": "0001124140-22-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000038/exas-20220502.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-04-29",
    "accession_number": "0000200406-22-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000047/jnj-20220428.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-04-29",
    "accession_number": "0001551152-22-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000012/abbv-20220429.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-04-29",
    "accession_number": "0001551152-22-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000010/abbv-20220429.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-04-29",
    "accession_number": "0000014272-22-000112",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427222000112/bmy-20220429.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-04-29",
    "accession_number": "0001104659-22-052847",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922052847/tm2213933d1_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-04-28",
    "accession_number": "0001104659-22-051588",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465922051588/tm2213615d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-04-28",
    "accession_number": "0000059478-22-000130",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000130/lly-20220428.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-04-28",
    "accession_number": "0000882095-22-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209522000010/gild-20220428.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-04-28",
    "accession_number": "0001157523-22-000494",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752322000494/a52699629.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-04-27",
    "accession_number": "0000318154-22-000019",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815422000019/amgn-20220427.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-04-27",
    "accession_number": "0001048477-22-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000015/bmrn-20220427.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-04-27",
    "accession_number": "0001628280-22-010664",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022010664/vrt-20220427.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-04-26",
    "accession_number": "0001124140-22-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000028/exas-20220426.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-04-21",
    "accession_number": "0001104659-22-047977",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465922047977/tm2212593d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-04-21",
    "accession_number": "0001104659-22-048450",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922048450/tm2213254d1_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-04-21",
    "accession_number": "0001104659-22-048091",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465922048091/tm2213170d1_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-04-21",
    "accession_number": "0001193125-22-112139",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312522112139/d329540d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-04-20",
    "accession_number": "0000078003-22-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000062/pfe-20220420.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-04-19",
    "accession_number": "0000200406-22-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000038/jnj-20220419.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-04-18",
    "accession_number": "0001140361-22-014868",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122014868/brhc10036367_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-04-15",
    "accession_number": "0001104659-22-046150",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922046150/tm2212735d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-04-14",
    "accession_number": "0000059478-22-000117",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000117/lly-20220414.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-04-13",
    "accession_number": "0001104659-22-045308",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922045308/tm2212581d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-04-12",
    "accession_number": "0000078003-22-000057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000057/pfe-20220411.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-04-11",
    "accession_number": "0001193125-22-101074",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/d520384d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-04-08",
    "accession_number": "0001104659-22-044050",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922044050/tm2212230d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-04-05",
    "accession_number": "0001193125-22-096176",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/d343633d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-04-05",
    "accession_number": "0000950170-22-005381",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017022005381/srpt-20220331.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-04-04",
    "accession_number": "0001193125-22-094409",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522094409/d259809d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-03-29",
    "accession_number": "0001193125-22-088144",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312522088144/d284315d8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-03-25",
    "accession_number": "0000310158-22-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000031015822000006/mrk-20220322.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-03-21",
    "accession_number": "0001140361-22-010251",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122010251/brhc10035425_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-03-17",
    "accession_number": "0001140361-22-009916",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122009916/brhc10035347_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-03-17",
    "accession_number": "0001193125-22-077831",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522077831/d336905d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-03-14",
    "accession_number": "0001104659-22-033098",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922033098/tm229163d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-03-14",
    "accession_number": "0001193125-22-074141",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312522074141/d289220d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-03-08",
    "accession_number": "0001104659-22-031232",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922031232/tm222431d2_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-03-07",
    "accession_number": "0001104659-22-030888",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922030888/tm228518d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-03-07",
    "accession_number": "0001157523-22-000294",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322000294/a52589930.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-03-04",
    "accession_number": "0001104659-22-030613",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465922030613/tm228136d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-03-03",
    "accession_number": "0001140361-22-007672",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122007672/ny20002727x7_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-03-02",
    "accession_number": "0001140361-22-007493",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122007493/ny20002727x6_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-02-28",
    "accession_number": "0001104659-22-027659",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922027659/tm227842d1_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-02-25",
    "accession_number": "0001193125-22-052558",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522052558/d290205d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-02-24",
    "accession_number": "0001140361-22-006591",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122006591/brhc10034437_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-02-24",
    "accession_number": "0001193125-22-051058",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312522051058/d318366d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2022-02-24",
    "accession_number": "0001193125-22-051135",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312522051135/d87894d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-02-24",
    "accession_number": "0001140361-22-006515",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122006515/brhc10034388_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2022-02-24",
    "accession_number": "0001104659-22-026592",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465922026592/tm227574d1_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-02-23",
    "accession_number": "0001048477-22-000008",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000008/bmrn-20220223.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-02-23",
    "accession_number": "0001628280-22-003424",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022003424/vrt-20220223.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-02-22",
    "accession_number": "0001140361-22-006206",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122006206/ny20002727x5_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-02-22",
    "accession_number": "0001193125-22-048514",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522048514/d302710d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-02-22",
    "accession_number": "0001124140-22-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000020/exas-20220222.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-02-16",
    "accession_number": "0000200406-22-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000017/jnj-20220215.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-02-16",
    "accession_number": "0001104659-22-024075",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922024075/tm226842d1_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2022-02-16",
    "accession_number": "0001770787-22-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078722000004/txg-20220216.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-02-15",
    "accession_number": "0001140361-22-005502",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122005502/ny20002727x2_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2022-02-14",
    "accession_number": "0001048477-22-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847722000005/bmrn-20220214.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-02-11",
    "accession_number": "0000914475-22-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000009/nbix-20220211.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-02-10",
    "accession_number": "0001110803-22-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000007/ilmn-20220210.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-02-10",
    "accession_number": "0001157523-22-000175",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752322000175/a52572231.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-02-09",
    "accession_number": "0001140361-22-004274",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122004274/brhc10033684_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2022-02-08",
    "accession_number": "0000078003-22-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800322000003/pfe-20220208.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-02-08",
    "accession_number": "0001558370-22-000883",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000155837022000883/incy-20220208x8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-02-07",
    "accession_number": "0000318154-22-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815422000005/amgn-20220207.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-02-04",
    "accession_number": "0000014272-22-000047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427222000047/bmy-20220204.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-02-04",
    "accession_number": "0001804220-22-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422022000004/regn-20220204.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2022-02-03",
    "accession_number": "0001104659-22-011130",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465922011130/tm222755d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-02-03",
    "accession_number": "0000059478-22-000016",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000016/lly-20220203.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-02-03",
    "accession_number": "0000875045-22-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504522000003/biib-20220203.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-02-02",
    "accession_number": "0000200406-22-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000015/jnj-20220128.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2022-02-02",
    "accession_number": "0001551152-22-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115222000003/abbv-20220202.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-02-01",
    "accession_number": "0000882095-22-000003",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209522000003/gild-20220201.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-02-01",
    "accession_number": "0001104659-22-010300",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922010300/tm224824d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2022-01-31",
    "accession_number": "0001193125-22-022446",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312522022446/d275834d8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2022-01-31",
    "accession_number": "0001193125-22-023401",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312522023401/d275986d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2022-01-31",
    "accession_number": "0001193125-22-022381",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312522022381/d295583d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-01-31",
    "accession_number": "0001140361-22-003182",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036122003182/brhc10033283_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-01-28",
    "accession_number": "0001124140-22-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000013/exas-20220125.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2022-01-26",
    "accession_number": "0000875320-22-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532022000003/vrtx-20220126.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-01-25",
    "accession_number": "0000200406-22-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000012/jnj-20220125.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-01-20",
    "accession_number": "0001104659-22-005729",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922005729/tm223965d1_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2022-01-14",
    "accession_number": "0001104659-22-004420",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465922004420/tm222684d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2022-01-11",
    "accession_number": "0001110803-22-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080322000003/ilmn-20220110.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001140361-22-001018",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036122001018/brhc10032672_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001104659-22-002403",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465922002403/tm222431d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001682852-22-000007",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000007/mrna-20220110.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001124140-22-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000009/exas-20220110.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001124140-22-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414022000005/exas-20220106.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001193125-22-005024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522005024/d36987d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0000950170-22-000205",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017022000205/srpt-20220110.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001104659-22-002524",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922002524/tm222429d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2022-01-10",
    "accession_number": "0001157523-22-000039",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752322000039/a52559698.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2022-01-06",
    "accession_number": "0000200406-22-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2022-01-06",
    "accession_number": "0001104659-22-001923",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465922001923/tm221957d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2022-01-06",
    "accession_number": "0000914475-22-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447522000004/nbix-20220106.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2022-01-06",
    "accession_number": "0001628280-22-000426",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828022000426/vrt-20211231.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2022-01-05",
    "accession_number": "0001104659-22-001275",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465922001275/tm221614d1_8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2022-01-04",
    "accession_number": "0001682852-22-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285222000004/mrna-20220104.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2022-01-04",
    "accession_number": "0001193125-22-001706",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312522001706/d251998d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-12-30",
    "accession_number": "0001104659-21-154482",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921154482/tm2136572d1_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-12-23",
    "accession_number": "0000914475-21-000064",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000064/nbix-20211222.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-12-23",
    "accession_number": "0001104659-21-153200",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921153200/tm2136160d1_8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-12-20",
    "accession_number": "0001193125-21-362387",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521362387/d163524d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-12-17",
    "accession_number": "0001104659-21-151213",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921151213/tm2135667d2_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-12-16",
    "accession_number": "0001104659-21-150570",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921150570/tm2135667d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-12-16",
    "accession_number": "0001193125-21-359144",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312521359144/d246572d8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-12-15",
    "accession_number": "0000078003-21-000118",
    "description": "PFIZER 8-K DECEMBER 9, 2021",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000118/pfe-20211209.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-12-15",
    "accession_number": "0001193125-21-357380",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312521357380/d212746d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-12-15",
    "accession_number": "0001193125-21-357968",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/d265991d8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-12-10",
    "accession_number": "0001193125-21-354132",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000119312521354132/d124536d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-12-10",
    "accession_number": "0001104659-21-148281",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921148281/tm2135090d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-12-07",
    "accession_number": "0001140361-21-040536",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121040536/brhc10031559_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-30",
    "accession_number": "0001157523-21-001456",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321001456/a52542691.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-11-29",
    "accession_number": "0001124140-21-000101",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000101/exas-20211129.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-11-29",
    "accession_number": "0001104659-21-144087",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921144087/tm2134036d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-11-26",
    "accession_number": "0001140361-21-039510",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/brhc10031117_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-11-24",
    "accession_number": "0001140361-21-039298",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121039298/brhc10031197_8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-11-22",
    "accession_number": "0000914475-21-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000062/nbix-20211122.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-11-19",
    "accession_number": "0000078003-21-000114",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000114/pfe-20211115.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-11-19",
    "accession_number": "0001193125-21-334519",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312521334519/d514669d8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-11-17",
    "accession_number": "0001193125-21-331813",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312521331813/d257656d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-17",
    "accession_number": "0000950170-21-004713",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000095017021004713/srpt-20211115.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-17",
    "accession_number": "0001104659-21-140588",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465921140588/tm2133126d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-11-16",
    "accession_number": "0001140361-21-038020",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121038020/brhc10030855_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-11-15",
    "accession_number": "0000200406-21-000072",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000072/jnj-20211115.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-11-09",
    "accession_number": "0001104659-21-136034",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921136034/tm2132228d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-09",
    "accession_number": "0001157523-21-001375",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321001375/a52525640.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001804220-21-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422021000031/regn-20211104.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001193125-21-319285",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521319285/d603727d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001110803-21-000044",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000044/ilmn-20211104.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001193125-21-319413",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521319413/d157027d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001104659-21-134389",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921134389/tm2131935d1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-04",
    "accession_number": "0001193125-21-319942",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521319942/d255322d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-11-03",
    "accession_number": "0001193125-21-318400",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312521318400/d106684d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-11-03",
    "accession_number": "0001140361-21-036328",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121036328/brhc10030336_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-11-03",
    "accession_number": "0001770787-21-000048",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000048/txg-20211103.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0000078003-21-000104",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000104/pfe-20211102.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0000318154-21-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815421000042/amgn-20211102.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0000875320-21-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000031/vrtx-20211102.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0001104659-21-133095",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921133095/tm2131721d1_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0001558370-21-013984",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000155837021013984/incy-20211102x8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-11-02",
    "accession_number": "0001124140-21-000095",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000095/exas-20211102.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-11-01",
    "accession_number": "0000914475-21-000057",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000057/nbix-20211101.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-11-01",
    "accession_number": "0001193125-21-315408",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521315408/d248934d8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-10-29",
    "accession_number": "0001551152-21-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000028/abbv-20211029.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K/A",
    "filing_date": "2021-10-29",
    "accession_number": "0001193125-21-311603",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312521311603/d244561d8ka.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-10-28",
    "accession_number": "0001104659-21-130675",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921130675/tm2131077d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2021-10-28",
    "accession_number": "0000882095-21-000024",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209521000024/gild-20211028.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-10-28",
    "accession_number": "0001193125-21-310422",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521310422/d240930d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-10-28",
    "accession_number": "0001104659-21-130731",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921130731/tm2131101d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-10-27",
    "accession_number": "0000014272-21-000223",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427221000223/bmy-20211027.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-10-27",
    "accession_number": "0001048477-21-000029",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847721000029/bmrn-20211027.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-10-27",
    "accession_number": "0001193125-21-308643",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521308643/d246329d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-10-26",
    "accession_number": "0000059478-21-000213",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000213/lly-20211026.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-10-20",
    "accession_number": "0000875045-21-000049",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000049/biib-20211020.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-10-19",
    "accession_number": "0000200406-21-000067",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000067/jnj-20211019.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-10-18",
    "accession_number": "0001140361-21-034722",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121034722/brhc10029896_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-10-15",
    "accession_number": "0000950157-21-001099",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015721001099/form8-k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-10-15",
    "accession_number": "0001193125-21-300047",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000119312521300047/d228298d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-10-13",
    "accession_number": "0001193125-21-297436",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521297436/d162379d8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-10-12",
    "accession_number": "0000200406-21-000063",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000063/jnj-20211012.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-09-28",
    "accession_number": "0001104659-21-120276",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921120276/tm2128728d1_8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-09-27",
    "accession_number": "0001564590-21-048961",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000156459021048961/srpt-8k_20210927.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-09-16",
    "accession_number": "0001104659-21-116352",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465921116352/tm2127757d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-09-15",
    "accession_number": "0001124140-21-000088",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000088/exas-20210915.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-09-10",
    "accession_number": "0001193125-21-270093",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312521270093/d129207d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-09-08",
    "accession_number": "0001193125-21-267358",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521267358/d228732d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-09-08",
    "accession_number": "0001193125-21-267213",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521267213/d213876d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K/A",
    "filing_date": "2021-08-27",
    "accession_number": "0001628280-21-017684",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021017684/vrt-20210824.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-08-25",
    "accession_number": "0000059478-21-000190",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000190/lly-20210823.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-08-20",
    "accession_number": "0000200406-21-000061",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/jnj-20210819.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-08-20",
    "accession_number": "0001140361-21-029043",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000114036121029043/brhc10028249_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-08-20",
    "accession_number": "0001104659-21-108146",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921108146/tm2125413d1_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-08-19",
    "accession_number": "0001104659-21-107639",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921107639/tm2125525d1_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-08-18",
    "accession_number": "0001193125-21-250347",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000119312521250347/d340659d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-08-18",
    "accession_number": "0000950157-21-000850",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015721000850/form8-k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-08-17",
    "accession_number": "0000059478-21-000175",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000175/lly-20210811.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-08-10",
    "accession_number": "0001157523-21-001034",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321001034/a52474958.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-08-09",
    "accession_number": "0001140361-21-027569",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121027569/brhc10027837_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-08-09",
    "accession_number": "0001193125-21-240434",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521240434/d213858d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-08-05",
    "accession_number": "0001804220-21-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422021000023/regn-20210805.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-08-05",
    "accession_number": "0001193125-21-236922",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521236922/d209372d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-08-05",
    "accession_number": "0001110803-21-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000040/ilmn-20210805.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-08-05",
    "accession_number": "0001193125-21-237087",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521237087/d211192d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-08-05",
    "accession_number": "0001104659-21-100755",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921100755/tm2124237d1_8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-08-04",
    "accession_number": "0001140361-21-026829",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121026829/brhc10027562_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-08-04",
    "accession_number": "0001770787-21-000041",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000041/txg-20210804.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0000059478-21-000168",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000168/lly-20210803.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0000318154-21-000031",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815421000031/amgn-20210803.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0001558370-21-009865",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000155837021009865/incy-20210803x8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0001193125-21-234071",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521234071/d167868d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0000914475-21-000046",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000046/nbix-20210803.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-08-03",
    "accession_number": "0001157523-21-000978",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000978/a52470483.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-07-30",
    "accession_number": "0001551152-21-000021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000021/abbv-20210730.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-07-30",
    "accession_number": "0001193125-21-229599",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521229599/d198092d8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-07-29",
    "accession_number": "0001104659-21-097239",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921097239/tm2123400d1_8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2021-07-29",
    "accession_number": "0000882095-21-000018",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209521000018/gild-20210729.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-07-29",
    "accession_number": "0000875320-21-000024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000024/vrtx-20210729.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-07-29",
    "accession_number": "0001558370-21-009545",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021009545/bpmc-20210729x8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0000078003-21-000090",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000090/pfe-20210728.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0000014272-21-000184",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427221000184/bmy-20210728.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0001048477-21-000023",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847721000023/bmrn-20210728.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0001124140-21-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000081/exas-20210728.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0001558370-21-009477",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021009477/bpmc-20210728x8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-07-28",
    "accession_number": "0001628280-21-014613",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021014613/vrt-20210728.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-07-27",
    "accession_number": "0001193125-21-225743",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521225743/d194030d8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-07-27",
    "accession_number": "0001770787-21-000039",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000039/txg-20210726.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-07-22",
    "accession_number": "0000875045-21-000041",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000041/biib-20210722.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-07-22",
    "accession_number": "0001104659-21-094624",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000110465921094624/tm2122733d25_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-07-22",
    "accession_number": "0001104659-21-094995",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921094995/tm2122790d2_8k.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-07-21",
    "accession_number": "0000200406-21-000053",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000053/jnj-20210721.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-07-20",
    "accession_number": "0000899866-21-000061",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000089986621000061/alxn-20210720.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-07-20",
    "accession_number": "0001104659-21-093979",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921093979/tm2115665d4_8k.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-07-09",
    "accession_number": "0000078003-21-000087",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000087/pfe-20210706.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-07-02",
    "accession_number": "0001124140-21-000070",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000070/exas-20210630.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-06-24",
    "accession_number": "0000875320-21-000020",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000020/vrtx-20210623.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-06-21",
    "accession_number": "0001104659-21-083528",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921083528/tm2120148-1_8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-06-21",
    "accession_number": "0001193125-21-194456",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521194456/d188744d8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-06-16",
    "accession_number": "0001104659-21-082035",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000110465921082035/tm2119804d1_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-06-16",
    "accession_number": "0001104659-21-082076",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000110465921082076/tm2119616-1_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-06-16",
    "accession_number": "0001628280-21-012336",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021012336/vrt-20210615.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-06-15",
    "accession_number": "0001157523-21-000791",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000791/a52445497.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-06-15",
    "accession_number": "0001770787-21-000036",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000036/txg-20210610.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-06-08",
    "accession_number": "0000875045-21-000032",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000032/biib-20210602.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-06-07",
    "accession_number": "0001124140-21-000060",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000060/exas-20210607.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-06-04",
    "accession_number": "0001140361-21-019925",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121019925/brhc10025504_8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-06-04",
    "accession_number": "0001558370-21-008015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021008015/bpmc-20210602x8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-06-03",
    "accession_number": "0001193125-21-180657",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000119312521180657/d190548d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-06-03",
    "accession_number": "0001564590-21-031601",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000156459021031601/srpt-8k_20210603.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-06-02",
    "accession_number": "0001193125-21-178807",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312521178807/d150819d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-06-02",
    "accession_number": "0001104659-21-075400",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000110465921075400/tm2118189d2_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-06-02",
    "accession_number": "0001770787-21-000033",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000033/txg-20210530.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-06-01",
    "accession_number": "0000200406-21-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000040/jnj-20210601.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-06-01",
    "accession_number": "0001193125-21-177693",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521177693/d19128d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-06-01",
    "accession_number": "0001193125-21-177871",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521177871/d190382d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-06-01",
    "accession_number": "0001193125-21-177943",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312521177943/d136689d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-05-28",
    "accession_number": "0001110803-21-000037",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000037/ilmn-20210526.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-05-28",
    "accession_number": "0001104659-21-074104",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921074104/tm2117861d1_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-05-27",
    "accession_number": "0000310158-21-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000031015821000015/mrk-20210525.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-05-27",
    "accession_number": "0001193125-21-174261",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312521174261/d175510d8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-05-27",
    "accession_number": "0001104659-21-073209",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921073209/tm2117670d1_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-05-26",
    "accession_number": "0001157523-21-000719",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000719/a52436081.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-05-21",
    "accession_number": "0001193125-21-169325",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521169325/d175346d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-05-21",
    "accession_number": "0000914475-21-000040",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000040/nbix-20210519.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-05-20",
    "accession_number": "0001140361-21-018212",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121018212/brhc10024929_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-05-19",
    "accession_number": "0001193125-21-166678",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521166678/d165963d8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-05-19",
    "accession_number": "0000875320-21-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000018/vrtx-20210519.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-05-18",
    "accession_number": "0001193125-21-164670",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521164670/d168523d8k.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-05-18",
    "accession_number": "0001564590-21-028550",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000156459021028550/srpt-8k_20210518.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-05-17",
    "accession_number": "0001558370-21-007333",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021007333/bpmc-20210517x8k.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2021-05-14",
    "accession_number": "0001104659-21-066766",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000110465921066766/tm2116386d1_8k.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K/A",
    "filing_date": "2021-05-13",
    "accession_number": "0001140361-21-017123",
    "description": "8-K/A",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000114036121017123/brhc10024518_8ka.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-05-13",
    "accession_number": "0001157523-21-000657",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000657/a52428778.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-05-11",
    "accession_number": "0001140361-21-016824",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000114036121016824/brhc10024426_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-05-10",
    "accession_number": "0001104659-21-063958",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921063958/tm2115632d1_8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-05-10",
    "accession_number": "0001104659-21-063995",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921063995/tm2115665d3_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-05-06",
    "accession_number": "0001140361-21-016224",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121016224/brhc10024237_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-05-06",
    "accession_number": "0001804220-21-000015",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422021000015/regn-20210506.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-05-06",
    "accession_number": "0001193125-21-152536",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521152536/d343911d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-05-06",
    "accession_number": "0001193125-21-152675",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521152675/d347909d8k.htm"
  },
  {
    "company": "Natera",
    "form": "8-K",
    "filing_date": "2021-05-06",
    "accession_number": "0001104659-21-062394",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1604821/000110465921062394/tm2115387d1_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-05-05",
    "accession_number": "0001193125-21-151781",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000119312521151781/d915811d8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-05-05",
    "accession_number": "0000059478-21-000126",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000126/lly-20210503.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-05-05",
    "accession_number": "0000914475-21-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000035/nbix-20210505.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-05-05",
    "accession_number": "0001140361-21-015877",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121015877/brhc10024102_8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-05-05",
    "accession_number": "0001770787-21-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000028/txg-20210505.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-05-04",
    "accession_number": "0000078003-21-000062",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000062/pfe-20210504.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-05-04",
    "accession_number": "0001140361-21-015721",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_8k.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-05-04",
    "accession_number": "0001140361-21-015744",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000114036121015744/brhc10023913_8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-05-04",
    "accession_number": "0001104659-21-060485",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921060485/tm2114920d1_8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-05-04",
    "accession_number": "0001124140-21-000050",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000050/exas-20210504.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-05-03",
    "accession_number": "0001124140-21-000042",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000042/exas-20210427.htm"
  },
  {
    "company": "Sarepta Therapeutics",
    "form": "8-K",
    "filing_date": "2021-05-03",
    "accession_number": "0001564590-21-022707",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/873303/000156459021022707/srpt-8k_20210503.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-04-30",
    "accession_number": "0001551152-21-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000013/abbv-20210430.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-04-30",
    "accession_number": "0000899866-21-000037",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000089986621000037/alxn-20210430.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0001104659-21-056877",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921056877/tm2114316d1_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0000014272-21-000124",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427221000124/bmy-20210429.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0000882095-21-000010",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209521000010/gild-20210429.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0000875320-21-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000012/vrtx-20210429.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0001193125-21-140463",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521140463/d171743d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0001048477-21-000013",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847721000013/bmrn-20210429.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0001157523-21-000536",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752321000536/a52420138.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-04-29",
    "accession_number": "0001558370-21-005175",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021005175/bpmc-20210429x8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-04-28",
    "accession_number": "0001193125-21-135412",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521135412/d165928d8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-04-28",
    "accession_number": "0001628280-21-007808",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021007808/vrt-20210428.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-04-27",
    "accession_number": "0000059478-21-000117",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000117/lly-20210427.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-04-27",
    "accession_number": "0000318154-21-000017",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815421000017/amgn-20210427.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-04-27",
    "accession_number": "0001110803-21-000028",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000028/ilmn-20210427.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-04-26",
    "accession_number": "0000078003-21-000059",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000059/pfe-20210422.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-04-26",
    "accession_number": "0000200406-21-000030",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000030/jnj-20210422.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-04-23",
    "accession_number": "0001628280-21-007391",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021007391/vrt-20210421.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-04-22",
    "accession_number": "0000875045-21-000025",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000025/biib-20210422.htm"
  },
  {
    "company": "Johnson & Johnson",
    "form": "8-K",
    "filing_date": "2021-04-20",
    "accession_number": "0000200406-21-000024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040621000024/jnj-20210420.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-04-20",
    "accession_number": "0001104659-21-052229",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921052229/tm2113328d1_8k.htm"
  },
  {
    "company": "Vertex Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-04-20",
    "accession_number": "0000875320-21-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875320/000087532021000009/vrtx-20210416.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-04-20",
    "accession_number": "0001110803-21-000024",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000024/ilmn-20210419.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-04-16",
    "accession_number": "0001193125-21-118557",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521118557/d179323d8k.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-04-16",
    "accession_number": "0000914475-21-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000026/nbix-20210415.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-04-13",
    "accession_number": "0001193125-21-114845",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521114845/d113560d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-04-13",
    "accession_number": "0001193125-21-114200",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521114200/d60310d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-04-13",
    "accession_number": "0001193125-21-113586",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000119312521113586/d158901d8k.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-04-12",
    "accession_number": "0001193125-21-113304",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000119312521113304/d166405d8k.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-04-12",
    "accession_number": "0001558370-21-004140",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021004140/bpmc-20210410x8k.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-04-09",
    "accession_number": "0000875045-21-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000018/biib-20210407.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-04-06",
    "accession_number": "0001140361-21-011725",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121011725/brhc10022825_8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-04-06",
    "accession_number": "0001157523-21-000429",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000429/a52406941.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-04-05",
    "accession_number": "0001110803-21-000022",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000022/ilmn-20210405.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-03-29",
    "accession_number": "0001140361-21-010402",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121010402/brhc10022399_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-03-26",
    "accession_number": "0001104659-21-042458",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921042458/tm2110937d1_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-03-24",
    "accession_number": "0001193125-21-092736",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000119312521092736/d106859d8k.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-03-23",
    "accession_number": "0001140361-21-009508",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121009508/brhc10022120_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-22",
    "accession_number": "0001193125-21-089600",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312521089600/d117662d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-18",
    "accession_number": "0001193125-21-085884",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312521085884/d116121d8k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-03-18",
    "accession_number": "0001124140-21-000038",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000038/exas-20210318.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-03-18",
    "accession_number": "0001157523-21-000363",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000363/a52398331.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-16",
    "accession_number": "0000950157-21-000344",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015721000344/form8-k.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-03-15",
    "accession_number": "0001140361-21-008493",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000114036121008493/nc10017928x20_8k.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-03-12",
    "accession_number": "0001104659-21-035654",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465921035654/tm219217d1_8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-12",
    "accession_number": "0001193125-21-079640",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312521079640/d137699d8k.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-03-10",
    "accession_number": "0001682852-21-000010",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285221000010/mrna-20210310.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-03-10",
    "accession_number": "0001193125-21-076423",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000119312521076423/d105467d8k.htm"
  },
  {
    "company": "Karuna Therapeutics",
    "form": "8-K",
    "filing_date": "2021-03-09",
    "accession_number": "0001157523-21-000308",
    "description": "SCHOLAR ROCK HOLDING CORPORATION 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1727196/000115752321000308/a52392795.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-08",
    "accession_number": "0001193125-21-073186",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000119312521073186/d110728d8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-03-04",
    "accession_number": "0001140361-21-007317",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121007317/brhc10021324_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-03-04",
    "accession_number": "0001193125-21-068571",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000119312521068571/d151856d8k.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-03-04",
    "accession_number": "0000950157-21-000303",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015721000303/form8-k.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-03-03",
    "accession_number": "0001124140-21-000035",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000035/exas-20210303.htm"
  },
  {
    "company": "Moderna",
    "form": "8-K",
    "filing_date": "2021-02-25",
    "accession_number": "0001193125-21-055687",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1682852/000119312521055687/d118084d8k.htm"
  },
  {
    "company": "Seagen",
    "form": "8-K",
    "filing_date": "2021-02-25",
    "accession_number": "0001193125-21-055874",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1157601/000119312521055874/d100550d8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-02-25",
    "accession_number": "0001048477-21-000004",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000104847721000004/bmrn-20210225.htm"
  },
  {
    "company": "Ionis Pharmaceuticals",
    "form": "8-K",
    "filing_date": "2021-02-24",
    "accession_number": "0001140361-21-005959",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/874015/000114036121005959/brhc10020770_8k.htm"
  },
  {
    "company": "CRISPR Therapeutics",
    "form": "8-K",
    "filing_date": "2021-02-24",
    "accession_number": "0001628280-21-002945",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1674101/000162828021002945/vrt-20210224.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-23",
    "accession_number": "0001140361-21-005853",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121005853/brhc10020673_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-22",
    "accession_number": "0001140361-21-005563",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121005563/brhc10020610_8k.htm"
  },
  {
    "company": "BioMarin",
    "form": "8-K",
    "filing_date": "2021-02-22",
    "accession_number": "0001193125-21-050805",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1048477/000119312521050805/d124224d8k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-02-19",
    "accession_number": "0001104659-21-025501",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921025501/tm217190d1_8k.htm"
  },
  {
    "company": "Eli Lilly",
    "form": "8-K",
    "filing_date": "2021-02-17",
    "accession_number": "0000059478-21-000081",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000081/lly-20210216.htm"
  },
  {
    "company": "Blueprint Medicines",
    "form": "8-K",
    "filing_date": "2021-02-17",
    "accession_number": "0001558370-21-001112",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1597264/000155837021001112/bpmc-20210217x8k.htm"
  },
  {
    "company": "10x Genomics",
    "form": "8-K",
    "filing_date": "2021-02-17",
    "accession_number": "0001770787-21-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1770787/000177078721000005/txg-20210217.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-02-16",
    "accession_number": "0001193125-21-044891",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312521044891/d124092d8k.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-02-16",
    "accession_number": "0000899866-21-000021",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000089986621000021/alxn-20210216.htm"
  },
  {
    "company": "Exact Sciences",
    "form": "8-K",
    "filing_date": "2021-02-16",
    "accession_number": "0001124140-21-000026",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1124140/000112414021000026/exas-20210216.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-02-11",
    "accession_number": "0001110803-21-000012",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080321000012/ilmn-20210211.htm"
  },
  {
    "company": "Alnylam",
    "form": "8-K",
    "filing_date": "2021-02-11",
    "accession_number": "0001157523-21-000169",
    "description": "ALNYLAM PHARMACEUTICALS, INC. 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1178670/000115752321000169/a52377572.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-10",
    "accession_number": "0001140361-21-004119",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121004119/brhc10020074_8-k.htm"
  },
  {
    "company": "Incyte",
    "form": "8-K",
    "filing_date": "2021-02-09",
    "accession_number": "0001104659-21-016324",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/879169/000110465921016324/tm215720d1_8k.htm"
  },
  {
    "company": "Regeneron",
    "form": "8-K",
    "filing_date": "2021-02-05",
    "accession_number": "0001804220-21-000006",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/872589/000180422021000006/regn-20210205.htm"
  },
  {
    "company": "Illumina",
    "form": "8-K",
    "filing_date": "2021-02-05",
    "accession_number": "0000950157-21-000121",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/1110803/000095015721000121/form8-k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0001140361-21-003357",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000114036121003357/brhc10019731_8k.htm"
  },
  {
    "company": "Merck",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0001104659-21-011912",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/310158/000110465921011912/tm213179d2_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0001140361-21-003401",
    "description": "CURRENT REPORT",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121003401/brhc10019742_8k.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0000014272-21-000058",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000001427221000058/bmy-20210204.htm"
  },
  {
    "company": "Gilead Sciences",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0000882095-21-000005",
    "description": "FORM 8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/882095/000088209521000005/gild-20210204.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0001193125-21-028202",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000119312521028202/d52158d8k.htm"
  },
  {
    "company": "Alexion/AstraZeneca",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0000899866-21-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/899866/000089986621000009/alxn-20210204.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-02-04",
    "accession_number": "0000914475-21-000018",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000018/nbix-20210204.htm"
  },
  {
    "company": "AbbVie",
    "form": "8-K",
    "filing_date": "2021-02-03",
    "accession_number": "0001551152-21-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115221000003/abbv-20210203.htm"
  },
  {
    "company": "Biogen",
    "form": "8-K",
    "filing_date": "2021-02-03",
    "accession_number": "0000875045-21-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/875045/000087504521000005/biib-20210203.htm"
  },
  {
    "company": "Pfizer",
    "form": "8-K",
    "filing_date": "2021-02-02",
    "accession_number": "0000078003-21-000003",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800321000003/pfe-20210202.htm"
  },
  {
    "company": "Bristol-Myers Squibb",
    "form": "8-K",
    "filing_date": "2021-02-02",
    "accession_number": "0001140361-21-003133",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/14272/000114036121003133/brhc10019660_8k.htm"
  },
  {
    "company": "Amgen",
    "form": "8-K",
    "filing_date": "2021-02-02",
    "accession_number": "0000318154-21-000005",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/318154/000031815421000005/amgn-20210202.htm"
  },
  {
    "company": "Neurocrine Biosciences",
    "form": "8-K",
    "filing_date": "2021-02-02",
    "accession_number": "0000914475-21-000009",
    "description": "8-K",
    "url": "https://www.sec.gov/Archives/edgar/data/914475/000091447521000009/nbix-20210202.htm"
  }
]